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basis of SHI is much more fragile. Specifically, on the demand side, what are the reasons for social (or
public) health insurance to exist, even to dominate private health insurance in most developed countries?
With regard to supply, what do we know about the objectives and constraints of SHI managers? Finally,
economists can predict properties of the equilibrium characterizing private health insurance (PHI).
However, what is the likely outcome (“performance”) of SHI? At the normative level, one may ask,
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Abstract
The objective of this text is to develop the theory of social health insur-
ance (SHI; the expression used especially in the United States is “public
health insurance,” which will be viewed as one variant of SHI here).
While a good deal is known about the demand and supply of private
insurance, the theoretical basis of SHI is much more fragile. Speciﬁcally,
on the demand side, what are the reasons for social (or public) health
insurance to exist, even to dominate private health insurance in most
developed countries? With regard to supply, what do we know about
the objectives and constraints of SHI managers? Finally, economists
can predict properties of the equilibrium characterizing private health
insurance (PHI). However, what is the likely outcome (“performance”)
of SHI? At the normative level, one may ask, Should the balance be
shifted from SHI to PHI?
*The author would like to thank an anonymous referee and Patrick Eugster (University of
Zurich) for crticisms and suggestions and Boris Krey (University of Zurich) for providing
the case studies in Section 3.
1
Introduction and Overview
The objective of this text is to develop the theory of social health insur-
ance (SHI; the expression used especially in the United States is “public
health insurance,” which will be viewed as one variant of SHI here).
While a good deal is known about the demand and supply of private
insurance, the theoretical basis of SHI is much more fragile. Speciﬁcally,
on the demand side, what are the reasons for social (or public) health
insurance to exist, even to dominate private health insurance in most
developed countries? With regard to supply, what do we know about
the objectives and constraints of SHI managers? Finally, economists
can predict properties of the equilibrium characterizing private health
insurance (PHI). However, what is the likely outcome (“performance”)
of SHI? At the normative level, one may ask, Should the balance be
shifted from SHI to PHI?
Accordingly, the outline of this text is as follows. Section 2 starts by
reviewing the conventional theory of demand for insurance and health
insurance in particular. However, it also seeks to oﬀer explanations of
the demand of SHI, citing eﬃciency, public choice, and equity reasons.
They may explain the existence (but not necessarily the prominence)
of SHI. Section 3 is devoted to the supply of health insurance in general
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and SHI in particular, which comprises more dimensions than just price
and quantity. Section 4 reviews the properties of the optimal health
insurance contract for providing a benchmark especially with regard to
combating moral hazard. In Section 5, the question is asked whether
there are factors limiting the apparently inexorable growth of SHI.
Section 6 oﬀers a summary and concluding remarks.
2
The Demand for Social Health Insurance
2.1 Theory of Insurance Demand
The standard way to present the theory of insurance demand is using a
two-goods model, with wealth in the no-loss state and wealth in the loss
state constituting the two goods. Here, a simpler alternative, based on
the Von Neumann–Morgenstern (VNM, henceforth: risk-utility) func-
tion will be presented. In Figure 2.1, there are two levels of wealth, Wl
in the loss state and Wn in the no-loss state. The associated utilities
are U [Wl] and U [Wn], where U [Wl] < U [Wn], the bracket to be inter-
preted to mean that the utility function U(·) is to be evaluated at the
respective values of the argument. Expected utility is given by (see e.g.,
Zweifel and Breyer, 1997, ch. 6),
EU = π · U [Wl] + (1 − π)U [Wn],
Wl := W0 − L − P (I) + I, (2.1)
Wn := W0 − P (I),
with π denoting the probability of loss (0 < π < 1), P the premium,
and I the amount paid by insurance in the event of loss. In Figure 2.1,
186
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Fig. 2.1 The demand for insurance.
the case π = 1/2 is shown. Clearly, the expected utility EU is associated
with the expected value of wealth, EW . It is a linear combination of
utilities U [Wl] and U [Wn]. It is well-known that linear combination of
values lie on the connecting straight line.
Now consider an individual who has the possibility of escaping this
risky prospect, in which a high value and a low value of wealth may be
realized with a certain probability. Given that the alternative provid-
ing certainty would be ﬁnancially equivalent (W = EW ), a risk-averse
decision maker would opt for it. This means that the risk-utility func-
tion must pass above the point EU , e.g., through U [EW ] > EU(W ).
The remainder of the risk utility function can be constructed as follows.
The loss-state with probability π = 1 is no diﬀerent from the certain
unfavorable outcome, and likewise loss-state with probability π = 0 is
equivalent to the certain favorable outcome. Therefore, the risk-utility
function at π = 1 and π = 0 cannot diﬀer from the extreme points of
the linear combination (that deﬁnes EU(W )). On the whole, the risk-
utility function must run concave from below, i.e. U ′′(W ) < 0.
An interesting implication follows from indiﬀerence between risky
and certain alternatives, which are depicted as a horizontal line through
the point EU , intersecting the risk-utility function at point Q. The
associated value of wealth (point C) is called the certainty equivalent
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of wealth. It shows that risk-averse individuals accept a reduction in
their wealth if this permits them to escape the risky situation. The
more marked the curvature of the risk utility function, the more risk-
averse the individual considered, and the greater the diﬀerence between
the expected value of wealth EW and the certainty equivalent C. This
diﬀerence can also be interpreted as a willingness-to-pay (WTP) for
certainty.
Turning to insurance, a policy with full coverage in fact oﬀers cer-
tainty in terms of wealth. Therefore, risk-averse individuals also have
WTP for insurance if their assets are exposed to variability. In Fig-
ure 2.1, Pmax is the maximum total premium that such an individual
is willing to pay. It consists of two components. First, EL shows the
expected value of the loss. This is also called the actuarially fair pre-
mium. The excess of Pmax over EL is equivalent to the maximum load-
ing for administrative expense and proﬁt that an insurer oﬀering the
full coverage contract can charge the consumer depicted in Figure 2.1.
Clearly, this loading also depends on the degree of risk aversion of the
individual; without risk aversion, the risk utility-function would run
linear, causing Pmax and EL to coincide. Therefore, there would be no
WTP for insurance.
2.2 The Demand for Health Insurance
The model of the preceding section is not satisfactory for health insur-
ance because it is couched exclusively in terms of wealth. One approach
would be to enter health status H in the risk-utility function. A far
easier alternative is to continue to work with a risk-utility function in
terms of wealth only, but to make its shape depend on health status.
First, the risk-utility function conditional on good health has a higher
value than that conditional on bad health, i.e., Uh(W ) > Us(W ), for all
levels of wealth W . Second, however, it is not so much the diﬀerence in
levels but the diﬀerence in slopes that is crucial for the optimal amount
of coverage. The argument will be only developed for the case where
the premium is actuarially fair,
P (I) = πI. (2.2)
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Substituting Eq. (2.2) into Eq. (2.1), modiﬁed to comprise Uh(W ) for
the healthy state and Us(W ) for the sick state, and taking the ﬁrst-
order derivative with regard to insurance coverage I, one obtains
dEU
dI
= πU ′s [Wl] (−π + 1) + (1 − π)U ′h [Wn] (−π) = 0. (2.3)
Dividing this by π · (1 − π), one has
U ′s [Wl] = U
′
h [Wn] . (2.4)
Therefore, given actuarially fair premiums, the optimum for the poten-
tial buyer of health insurance is equality of the two marginal utilities of
wealth. This makes sense, because as long as additional wealth is worth
more in one state than the other, the consumer should reallocate wealth
between the two states.
Turning to Figure 2.2 (panel A), the upper risk-utility function runs
steeper throughout than the lower one, indicating that the marginal
utility of wealth is higher in the healthy state than in the sick state for
all values of W . The two parallel dashed lines show a possible solution
that satisﬁes the equality of marginal utilities as given by Eq. (2.4). The
optima are represented by points Q and R on the state-dependent risk-
utility functions. They imply that optimally wealth should be higher in
the healthy state than in the sick state. Therefore, insurance coverage
should not be complete but contain a degree of cost sharing (which
U, 
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Q U'h(W) 
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U's(W) 
Us(W) 
R
Wl W*s W*h Wh
W 
U, 
U' 
T
U'h(W) Uh(W) 
U's(W) 
Us(W) 
S
W
(A) Marginal utility of wealth high
       when healthy
(B) Marginal utility of wealth high
      when sick
l W*h W*s Wh
W 
Fig. 2.2 Optimal degree of coverage in health insurance.
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of course can also be justiﬁed on other grounds, in particularly, moral
hazard).
Turning to panel B, the situation is exactly reverse. Here, the lower-
valued risk utility function runs steeper than the higher-valued one
throughout. Applying the marginal utility criterion of Eq. (2.4) once
more, one obtains optimal points S and T . This time, these points indi-
cate that wealth optimally should be higher in the sick state than in
the healthy state. The interpretation is that possibly when an individ-
ual is ill, good accommodation, healthy food, and convenient clothing
are more important than in the healthy state. For such an individual,
health insurance, at least in the absence of moral hazard, should provide
compensation for suﬀering. While this is a possibility, on the whole a
higher marginal utility of wealth in the healthy state (the case of panel
(A)) should be considered more realistic. Many consumption activi-
ties (eating, but also travel and entertainment) can only be enjoyed
fully when in good health. Of course, there are additional considera-
tions calling for a degree of cost sharing, and arguing against contracts
that pay more than the medical expenditure needed for re-establishing
health. Moral hazard eﬀects need to be avoided, and separating con-
tracts (see Section 2.3.1) call for oﬀering less than complete coverage
to favorable risks.
Conclusion 1. The theory of insurance demand predicts that risk-
averse individuals derive beneﬁt at least on expectation from health
insurance, provided the premium does not contain an excessive loading
for administrative expense and proﬁt. To the extent that wealth is
particularly important when ill, optimal coverage may even contain a
compensation for suﬀering; however, this result may not hold under the
inﬂuence of moral hazard.
2.3 Why Social Health Insurance?
Most developed countries have some kind of collective ﬁnancing for
health services, either through tax (e.g., the Health Service of the
United Kingdom) or through their contributions to “social” health
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insurance (henceforth: SHI). This type of insurance is usually char-
acterized by mandatory membership, at least for the vast majority of
the population, open enrollment, and community rating, i.e., a prohi-
bition to charge premiums related to individual risk. From a normative
point of view, the institution of SHI can be defended on both eﬃciency
and equity grounds, whereas positive economics seeks to explain its
existence in democracies on the basis of public choice models.
2.3.1 Eﬃciency reasons: Characteristics of private health
insurance markets
SHI may be eﬃciency-enhancing if it mitigates or even eliminates pos-
sible market failures, viz. high cost of administration, asymmetry in
the distribution of information, altruism and free riding, and optimal
taxation.
(a) High cost of administration: The theory of the preced-
ing section was couched in terms of actuarially fair premi-
ums. This means that on expectation, insurance coverage is
costless because the premium revenue is redistributed back
entirely to consumers. In fact, however, premiums charged
by private health insurers contain a considerable loading for
acquisition, administrative expense, underwriting risk, and
proﬁt. One argument in favor of SHI is that thanks to its
compulsory nature, it saves on acquisition cost and thanks
to its uniformity, on administrative expense. Judging from
insurers’ accounts (which however do not single out health
insurance), these savings may amount to as much as
30 percent of premium revenue.
However, contributions to SHI come very close to being a
tax. In many countries (such as Canada and Sweden), they
are part of taxation; in other countries (such as Germany,
the Netherlands, and the United States), they are part of
the cost of labor and hence amount to a payroll tax. Even
where social health insurers charge an actual premium (as
in Switzerland), contributions cannot be reduced below the
premium of the most eﬃcient insurer, who must recover
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the cost of mandated beneﬁts. This means that there is
an excess burden associated with these contributions, in
analogy to income taxation. An estimate by Ballard et al.
(1985) puts the excess burden at 30 percent of tax revenue
in the United States, while a more recent estimate by Parry
(2001) arrives at 26 percent speciﬁcally for payroll taxes in
the United Kingdom. Therefore, social health insurance is
unlikely to be eﬃciency-enhancing on net with regard to
the loading.
(b) Asymmetric information: Ever since the seminal con-
tribution by Rothschild and Stiglitz (1976), private com-
petitive insurance markets are suspected to exhibit adverse
selection due to asymmetric information. If the insured has
more precise information on his individual risk distribution
than the insurer, the only possible Rothschild–Stiglitz equi-
librium is a separating one in which the most unfavorable
risk types are oﬀered complete coverage at actuarially fair
premiums. Lower risks obtain more favorable terms but are
rationed in terms of coverage. They would prefer to have
more coverage, but this would make their contract attrac-
tive to unfavorable risks. Compared to such an equilibrium,
SHI which forces all individuals into a pooling contract with
partial coverage can achieve a Pareto improvement: high
risks are made better oﬀ because they pay lower premiums
for the mandated part of their coverage, whereas favorable
risks beneﬁt from improved total (social plus private) cover-
age (Newhouse, 1996). However, it is unclear to what extent
asymmetric information on health risks is really a problem
these days since medical exams are used to determine the
risk of an insured.
(c) Altruism and free riding: Altruistic rich members of a
society may be willing to subsidize the provision of health
care to the poor, especially if they are more interested in the
health than in the subjective well-being of the poor (Pauly,
1970). Private charity fails to reach an eﬃcient allocation
since donations to the poor, whether in cash or in kind, have
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a public-good characteristic, increasing the utility not only
of the donor but also of other altruistic members of society.
Either a tax-ﬁnanced national health service (NHS) or SHI
with compulsory membership and contributions according
to ability to pay solve this free-rider problem of potential
donors.
(d) Optimal taxation when health and income are cor-
related: A related justiﬁcation of SHI is derived from the
theory of optimal taxation (Cremer and Pestieau, 1996). If
abilities cannot be observed by tax authorities, the extent
to which income taxation can be used for redistribution
from the high-skilled to the low-skilled is limited because
the high-skilled can always pretend to be low-skilled by
reducing their labor supply. However, if there is a neg-
ative correlation between ability and the risk of illness,
a mandatory SHI with uniform contributions implicitly
redistributes between the ability groups in the desired
fashion and thus improves social welfare. It must be empha-
sized, however, that this justiﬁcation departs from Paretian
welfare economics by postulating a speciﬁc redistributive
goal.
2.3.2 Equity reasons
A further justiﬁcation, also known as the “principle of solidarity,”
relates to the achievement of equality of opportunity. People diﬀer in
their health risk already at birth, and some indicators of risk are readily
observable. Moreover, with the rapid progress of genetic diagnostics and
the spread of tests during pregnancy, the ability to measure individual
health risks of newborns will become more and more pronounced. In
private health insurance (PHI), these diﬀerences in risk immediately
translate into diﬀerences in premiums so that those persons who are
endowed by nature with a lower stock of “health capital” and are thus
already disadvantaged, have to pay a higher price for the same coverage
on top of this. Behind the veil of ignorance, one would desire at least
an equalization of the monetary costs of illness.
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Table 2.1 Alternatives for achieving solidarity.
Alternatives Advantages Disadvantages References
Premium
subsidy
Current
transfer
Permits full
competition in
PHI (or SHI)
both in
premiums and
products and
full information
on risk
Means testing;
deﬁnition of
benchmark
contract
Pauly
et al.
(1992)
Lump sum
transfer for
lifetime
Means testing;
longevity risk
shifted to
beneﬁciaries
Regulation: Community rating
(uniform contributions)
Relieves public
budget
Induces cream
skimming and
RAS as secondary
regulation
Van de
Ven et al.
(2000)
Note: RAS = Risk Adjustment Scheme.
There are in principle two ways to achieve solidarity in health insur-
ance (see Table 2.1). First, PHI premiums can be subsidized for those
who would have to pay excessive contributions. The transfer could be
on a current basis or a lump sum, equal to the estimated present value
of future excess premiums over the whole expected life span of beneﬁcia-
ries. Both have the important advantage of permitting full competition
in PHI (or SHI), including insurers acquiring information about true
risk. Besides means testing and the need to deﬁne a benchmark con-
tract to determine the amount of the subsidy, the second variant has the
disadvantage of shifting the risk of longevity to beneﬁciaries. The sec-
ond alternative is a monopolistic SHI scheme with open enrollment and
community rating that prevents diﬀerences in health risk from being
translated into diﬀerences in contributions but induces cream skim-
ming and risk adjustment schemes (RAS, see below) as a secondary
neutralizing regulation.
2.3.3 Public choice reasons
In PHI, redistribution occurs purely by chance, from consumers who did
not suﬀer a loss during the life of the contract to those who do. By way
of contrast, social insurance mixes in elements of systematic redistribu-
tion. The fact that contributions are not (or not fully) graded according
to risk (OECD, 2004) alone serves to systematically redistribute wealth
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from high risks to low risks. In SHI, this redistribution not only aﬀects
wealth through its ﬁnancing side but its beneﬁt side as well, viz. medi-
cal services and health. This makes SHI an ideal means for a politician
who seeks oﬃce (or re-election) by catering to the interests of groups
who are suﬃciently organized to have an eﬀect on the outcome of an
election (Gouveia, 1997, Hindriks and De Donder, 2003, Tullock, 2003).
The redistributive eﬀects of SHI can be described as follows:
(a) Redistribution of wealth: Using SHI as a vehicle for systematic
redistribution has the important advantage that net payers have con-
siderable diﬃculty determining the systematic component of redistribu-
tion. For example, when the contribution to SHI amounts to a payroll
tax (as e.g. in Germany), high wage earners pay more for their health
insurance. However, they are uncertain about the systematic redistri-
bution component of their contribution because the expected value of
their beneﬁts may also be higher than average. This has two possible
reasons: Preventive eﬀort may be aﬀected negatively by a higher wage,
resulting in higher health costs, and demand for medical services may
increase because short-term disability beneﬁts usually increase with
wages, creating a spill-over moral hazard eﬀect (Zweifel and Manning,
2000). Therefore, their higher contribution appears “justiﬁed,” masking
a tax component which if collected as a tax would likely be opposed.
(b) Redistribution of medical care: There are two eﬀects here.
First, there is an income eﬀect because some individuals who would
have demanded less or no medical care without insurance coverage
now demand a positive amount of it (Nyman, 2003). Indeed there
is (macro) evidence suggesting that medical care is a normal good
(Gerdtham et al. (1992), Miller and Frech (2004), Zweifel et al. (2006)).
Insurance coverage for everyone then amounts to an in-kind redistri-
bution from the rich to the poor if the supply of medical services is
not inﬁnitely elastic and if the price elasticity of demand for medi-
cal care is not lower for the rich than the poor (which is doubtful,
see Newhouse and The Insurance Experiment Group (1993), ch. 11).
However, there is also a price eﬀect because health insurance boosts
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the “true” WTP for medical care depending on the rate of coinsur-
ance (Zweifel and Breyer, 1997, ch. 10). For example, if “true” WTP
is 100 and the rate of coinsurance is 25 percent, observed WTP is 400.
To the extent that rich individuals have higher true WTP to begin
with, they beneﬁt more strongly (in absolute terms) from this leverage
eﬀect of health insurance. Thus, the total redistributive eﬀect of SHI is
ambiguous.
(c) Redistribution of health: When it comes to health, altruism
is probably more marked than with regard to income, although com-
parative evidence seems to be lacking (the methodology for measur-
ing distributive preferences for health is still in its infancy, see Olsen
(2000)). Therefore, politicians can claim to have a mission when seeking
to guarantee “health for all” (the famous slogan of the World Health
Organization). Equal access to health insurance then may be seen as an
important factor for securing equal access to medical care, and to the
extent that medical care is eﬀective at the margin (for which there is
some evidence (see e.g., again Miller and Frech (2004) and Lichtenberg
(2004)), for securing equal health status, Culyer and Wagstaﬀ (1993)).
If SHI indeed contributes to winning votes and increasing the chance
of (re-)election of a democratic government, one would expect public
expenditure for it to increase around election time. One piece of avail-
able evidence relates to two types of public expenditure by the Dutch
government, expressed as GDP shares, between ca. 1956 and 1993, viz.
health (such as subsidies to hospitals) and tax contributions to social
insurance in general. Van Dalen and Swank (1996), cited in Zweifel
(2000a), ﬁnd that while public expenditure on health does not vary
around election time, transfers in favor of social insurance are system-
atically higher during the years prior, concurrent with, and after an
election. The estimated eﬀect is 13 percent, e.g., an increase from 8
to 9 percent of GDP. In addition, the share of the pensioners in the
population is signiﬁcantly related to both types of public expenditure.
Nowadays pensioners are not poor, but they do go to the polls. The
evidence thus is compatible with governments proposing SHI schemes
to beneﬁt pivotal voter groups.
2.3. Why Social Health Insurance? 197
Conclusion 2. While the eﬃciency reasons for social (health)
insurance have received much attention in the economics literature,
they are found not fully convincing. As to the equity reasons, tar-
geted premium subsidies emerge as an alternative to community rat-
ing. On the whole, the available empirical evidence suggests that
public choice factors (i.e., winning votes) may well be the crucial rea-
son for the existence and even more the growth of social (health)
insurance.
3
The Supply of Health Insurance
According to Conclusion 1 stated at the end of Section 2, governments
(and public administration) can be seen as the suppliers of SHI. In
systems of the National Health Service type, the government itself pro-
vides the insurance function while also acting as the organizer of med-
ical care. This type will be called “public health insurer.” However, in
a majority of industrialized countries, health insurers are not incorpo-
rated in the government’s budget; they will be called “(competitive)
social health insurers.” In both cases, the supply of health insurance
has several dimensions. It can be characterized by the comprehensive-
ness and structure of the beneﬁt package, the amount of eﬀort devoted
to risk selection, the price of coverage, the amount of integration of
healthcare providers, and the market structure of health insurance.
3.1 Beneﬁt Package
An unregulated private insurer has the option to specify its oﬀer along
three dimensions (Zweifel and Breyer, 1997, p. 159). First, it can decide
to cover only certain types of services and leave out others, for instance,
198
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Type of Service 
Amount of Benefits Type of Provider 
Fig. 3.1 Diﬀerentiation of beneﬁts.
to include inpatient and exclude outpatient care, which is not uncom-
mon in low-income countries (Musau, 1999). Second, it can diﬀerentiate
its oﬀer by covering or excluding services oﬀered by certain provider
categories, for instance, including only physicians registered with a pub-
lic agency and excluding those who are not. Third, it may determine
the amount of the beneﬁts paid in case of sickness. The compensation
may state a certain quantity of services, the compensation per unit of
consumption, or the limit up to which expenditures are refunded (see
Figure 3.1).
There are many possible combinations between the three dimen-
sions, creating opportunity for product innovation and the building of
proﬁtable market segments. The optimal choice is inﬂuenced by sev-
eral factors listed in Table 3.1, which are discussed starting with the
insurer’s point of view and moving toward demand-side considerations
Table 3.1 Factors aﬀecting the size of the beneﬁt package.
Factor serves to increase (+)/decrease (−) beneﬁt package
Factor
Private health
insurance
Community-based
Health Insurance
Public health
insurance
Risk aversion of insurer +/− +/− ↓ n.a.
Synergies among beneﬁts + + ↓ n.a.
Moral hazard − − ↓ − ↑
Diversity of preferences + + ↓ + ↓
Diversity of risks + + ↓ + ↓
Emergence of new health
risks
+ + ↓ + ↑
Regulation + + + ↑
Fraud and abuse − − ↑ − ↓
Note: ↑ Reinforcement of relationship, ↓ Attenuation of relationship, n.a.: not applicable.
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and regulatory and institutional factors that aﬀect insurers’ decision
making.
3.1.1 Risk aversion of insurer
The relevance of risk aversion for the behavior of insurers has been the
subject of continued debate (Greenwald and Stiglitz, 1990, Chen et al.,
2001). In industrial countries, owners of insurance companies can be
assumed to hold fully diversiﬁed portfolios. As such, they are exposed
only to nondiversiﬁable risk, which is reﬂected in the beta of the com-
pany (the slope of the regression linking the company’s expected rate
of return to the expected rate of return prevailing on the capital market
at large). Therefore, diversiﬁcation is only in the interest of sharehold-
ers to the extent that it lowers the company’s (positive) value of beta.
Management, being much less diversiﬁed in its assets, has an interest
in diversiﬁcation of its own. Therefore, the extent to which it actually
engages in diversiﬁcation of the underwriting portfolio is a question of
corporate governance.
Assuming an interest in risk diversiﬁcation caused by risk aversion,
its impact on the beneﬁt package can still go either way (see Table 3.1).
To the extent that, e.g., inpatient and outpatient services constitute
complements rather than substitutes, they are positively correlated.
Including both in the beneﬁts package then adds to the variance of
liabilities ceteris paribus, which runs counter the interests of a risk-
averse insurer. Beneﬁts triggered by communicable diseases have the
same eﬀect, motivating their strict limitation. Even if there is negative
correlation, it should be noted that risk diversiﬁcation does not nec-
essarily imply more complete beneﬁt packages at the individual level
since the insurer can oﬀer diﬀerent packages to diﬀerent client groups.
To the extent that domestic investors in low-income countries can-
not rely on a suﬃciently developed capital market (or are prevented
from full international diversiﬁcation), their risk aversion is more likely
to be relevant for management decisions. Management, ﬁnding itself in
a similar situation, will tend to further reinforce this tendency (assum-
ing corporate governance to be imperfect). In community-based health
insurance, in particular, which amounts to a mutual insurer, owners
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are individuals and households, whose degree of asset diversiﬁcation
is still far lower. This calls for an even keener interest in diversiﬁca-
tion. However, the low income level of enrollees may force most such
schemes to stick to narrowly deﬁned products in spite of a basic need
for diversiﬁcation (Musau, 1999).
A public health insurer is unlikely to be signiﬁcantly risk averse with
respect to its ﬁnancial results. Its opportunities to shift the ﬁnancial
risk to the government – who can resort to printing money if necessary –
and the responsibility for failure are numerous. Therefore, risk aversion
cannot have much importance in determining the beneﬁt package.
3.1.2 Synergies among beneﬁts
Synergies denote economies of scope in production, distribution, and
marketing that are unrelated to risk diversiﬁcation eﬀects. They cause
insurers to beneﬁt from oﬀering a combination of beneﬁts rather than a
single beneﬁt. In production, synergies arise when the costs of writing
and executing contracts (speciﬁcally the processing of claims, cf. the
term µπ in Eq. (3.2) of Section 3.3) do not rise proportionally with
the number of beneﬁts, resulting in decreasing expected unit cost. In
distribution, the same channel may be used for selling additional prod-
ucts. In marketing, brand advertising beneﬁts all the products sold by
a given insurer.
In a public insurance system, synergies are not a very relevant crite-
ria for a decision maker who aims at providing public and merit goods
to the population (see Section 3.3). This objective tends to override the
economic justiﬁcation of extending beneﬁts purely because of synergies.
3.1.3 Moral hazard
The eﬀect of ex-post moral hazard (for a deﬁnition, see Section 3.3.6)
on the beneﬁt package can be illustrated as follows. Assume that con-
sumers’ willingness to pay (WTP) out of pocket for a medical service or
product is approximately given by the linear demand function C”C of
Figure 3.2. In the case of health insurance with a 50 percent coinsurance
rate, maximum WTP is doubled, from C ′ to C ′′. More generally, the
demand function is rotated outward to become the eﬀective demand
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Fig. 3.2 Ex-post moral hazard. A: equilibrium quantity without insurance coverage;
B: equilibrium quantity with 50 percent coinsurance; B − A: ex-post moral hazard eﬀect
with a coinsurance rate of 50 percent; and C − A: ex-post moral hazard eﬀect in a scheme
without coinsurance.
function C ′′C. The lower the rate of coinsurance, the more pronounced
this rotation is. With no copayment at all (as is often the case with
tax-funded schemes), the curve runs fully vertical from C.
Therefore, the market equilibrium shifts from point E to F , with
a higher quantity of the service or product transacted. In terms of
Eq. (3.1) of Section 3.3, the beneﬁts to be paid (I) increase, resulting
in an ex-post moral hazard eﬀect. As will be argued in Section 3.3.6, a
decrease in the rate of coinsurance causes both parts of the loading and
hence the premium to increase. This creates a negative income eﬀect
(shifting the demand curve inward) that is neglected for simplicity.
The moral hazard eﬀect is of relevance to the choice of beneﬁt pack-
age because it comes to bear with each additional item in the pack-
age. The more complete the package, the larger the loading component
in the gross premium and hence the larger the net cost of insurance.
Therefore, moral hazard considerations should lead an insurer to exer-
cise caution in expanding the package. Speciﬁcally, it would want to
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add services characterized by low price elasticity of demand because
the moral hazard eﬀect is more limited in this case. In Figure 3.2,
lower price elasticity means that for a given maximum WTP such as
C ′, the demand function runs steeper, causing point C to shift toward
the origin. This serves to reduce the diﬀerence between the true and
the observed demand curve, and hence the size of the ex-post moral
hazard eﬀect.
Moral hazard may be less of a problem in community-based schemes
(see Table 3.1), which usually consist of small risk pools. First, asym-
metric information is less pronounced in a small (often rural) commu-
nity, where each member of the pool can easily monitor the behavior
of the others.
In a public insurance system, moral hazard sooner or later becomes
an important consideration in the determination of the beneﬁt package.
The consumption of health care services usually entails little or no
cost sharing for the user, which means that in Figure 3.2 the vertical
observed demand function applies. Therefore, the public insurer must
ﬁnance the maximum quantity C times the unit price CD for each
beneﬁt added. It is subject to the ex-post moral hazard eﬀect to a
higher degree than a private insurer, who would oﬀer policies with
varying degrees of cost sharing. Unless contributions (often levied in
the guise of a payroll tax) or tax allocations are increased accordingly,
the scheme ends up in deﬁcit.
3.1.4 Diversity of preferences
The creation of a beneﬁt package depends on its value to consumers.
Consumers will demand a package that combines beneﬁts to the extent
that their marginal rate of substitution is equal on expectation. A
unit of beneﬁt will be added to the package until its ratio of expected
marginal utility to the premium increase occasioned is equal across all
beneﬁts. This expected value importantly depends on the amount of
risk aversion and the relevant probabilities of loss. Diﬀerences in loss
probabilities are addressed below.
Diversity of preferences among the insured causes their optimality
conditions to be satisﬁed at diﬀerent (sometimes zero) levels of beneﬁts.
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In order to attract consumers, insurers will customize their products
in an attempt to maximize expected proﬁt. The diversity of prefer-
ences may relate to, e.g., the amount of the deductible, the rate of
coinsurance, and the limits on beneﬁts, as well as type of service (for
instance alternative medicine) and type of provider. In this way, per-
manent innovation and adjustment to changing demand occurs. As a
general rule, product diﬀerentiation is costly.
Public health insurers cannot accommodate diﬀerent preferences
almost by deﬁnition because their mission is to administer the entire
population (or at least a great majority of it) a uniform product. The
more preferences in fact diﬀer, the more likely is it that a uniform
national health insurance scheme burdens the country with a loss of
eﬃciency (for some empirical evidence, see Section 5.4).
3.1.5 Diversity of risks
Diversity of risks (in the sense of diﬀerences in loss probabilities) pro-
mote a diﬀerentiation of degrees of coverage, combined with a diﬀerenti-
ation of premiums. If insurers are unable to assess risks, a diﬀerentiation
of premiums cannot take place, which encourages the purchase of excess
coverage by high risks and reduced coverage by low risks. Therefore,
the insurer runs the danger of incurring a deﬁcit when expanding the
beneﬁt package under these conditions. The same argument holds when
the insurer is prevented from diﬀerentiating premiums by a mandate to
take on every applicant on the same conditions. When combined with
asymmetric information, diversity of risks thus hampers the creation
of comprehensive beneﬁt packages (see Table 3.1).
For a public health insurer, uniformity of beneﬁts is part of its mis-
sion because it acts on behalf of the government, whose likely objective
is to provide citizens with a maximum of public and so-called merit
goods. By assumption, public goods are enjoyed by everyone to the
same degree; therefore, if the government views access to health care
as a public good, its insurance branch must act accordingly, guarantee-
ing equal access through equal beneﬁts. Diversity of risks can hardly be
reﬂected in a diversity of (planned) beneﬁts under these circumstances.
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3.1.6 Emergence of new health risks
New health risks give rise to demand for an extension of the beneﬁt
package. However, even under competitive conditions insurers will not
adjust to this demand immediately. First, they need time to assess the
probability of loss π. Second, an extension of the beneﬁt package calls
for a premium adjustment, which in turn usually requires a cancellation
of the policy. It takes new business to provide the insurer with the
opportunity to test consumers’ WTP for the added beneﬁt in the guise
of a higher premium. Even under competitive conditions, new health
risks will thus be covered only with a certain delay (see Table 3.1).
This is even more true of community-based schemes, which still have
to deal with communicable diseases causing individual illness probabili-
ties to be positively correlated. Extending the beneﬁt package therefore
may increase the risk of ruin, especially since these schemes operate in
areas where close personal contact is very common (Nugroho et al.,
2001).
A public insurer is called upon to cover emerging new risks because
public health is at stake. While hardly concerned by the risk of ruin,
it still has to be taken into account that the government possibly must
cover high deﬁcits.
3.1.7 Regulation
Regulation typically concerns not only premiums but also products
because premium regulation can be subverted by product diﬀerenti-
ation. Premium regulation typically prevents insurers from diﬀerenti-
ating premiums according to true risk. A given uniform premium is
associated with a contribution to expected proﬁt in the case of a low
risk but cause of an expected deﬁcit in the case of a high risk. Therefore,
it becomes vital for an insurer to attract as many low risks as possible.
One way to achieve this is to modify the beneﬁt package, excluding
services that attract high risks. More generally, insurers will use ben-
eﬁts to compete with diﬀerentiated products since price competition
is hindered by the regulator. In all, premium regulation in principle
serves to increase the variety of beneﬁt packages in the market, unless
product regulation neutralizes this tendency.
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Overall, regulation of insurance can be eﬃciency-reducing, in par-
ticular if it seeks to minimize the social cost of insolvency by avoid-
ing insolvency altogether (see Appendix B and Table B.1). Typically,
eﬃciency-enhancing regulation limits itself to mitigating the social
costs of insolvencies while permitting them in principle. An overview
is provided by Appendix Table B.2.
In most community-based schemes, the premium is determined by
members themselves. The resulting premium is uniform; however, this
triggers but little risk selection eﬀort through product diﬀerentiation
(see Section 3.2) because the risk pool is very homogeneous. Moreover,
most schemes are local monopolies; therefore, they have little incentive
to compete for members with diﬀerentiated beneﬁt packages. An exam-
ple in point is the Mburahati Health Trust Fund in Tanzania (Musau,
1999), which only oﬀers coverage for outpatient care and a small con-
tribution toward public hospital care.
Since public health insurance can be seen as being subject to a
maximum degree of regulation (see Appendix Table B.1), it is also
most strongly exposed to it in the determination of the beneﬁt package.
Expanding beneﬁts is in the logic of a government who seeks to provide
a maximum amount of public goods; therefore, a strong tendency in
this direction can be expected.
3.1.8 Fraud and abuse
Fraud and abuse may occur at three levels. First, it constitutes an
extreme form of moral hazard on the part of the insured, which however
may be countered by the insurer by inspections and curtailment or even
denial of beneﬁts. Second, providers of services may act fraudulently;
here, the countermeasure is to pattern their remuneration in a way to
give them an incentive for honesty (revelation principle, see e.g. Laﬀont
and Tirole (1993), ch. 1). Third, fraud and abuse may occur when
health care providers aﬀect their purchase. Being one step remote, it
cannot easily be neutralized by the insurer unless competition between
providers is strong.
Providers of medical supplies may ex-ante fraud physicians and hos-
pitals, e.g., by oﬀering money payments in exchange for their more
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expensive products being used for treatment rather than cheaper prod-
ucts from competing suppliers. These products tend to be also of lower
quality and quantity since corrupted suppliers have to recover their
bribery payments through their sales margins. This results in insur-
able medical services being of lower quality at a given price. An insurer
considering the extension of its beneﬁts package thus has to take into
account that such an addition may well be of lower quality, thus failing
to induce much WTP in terms of higher premiums. This makes more
comprehensive beneﬁt packages rather unattractive (see Table 3.1). For
instance, some private health insurers in Thailand decided to terminate
coverage for ambulatory care because auditing the bills and checking
for fraud became too costly (Health Systems Research Institute, 2002,
p. 7).
A public health insurer in principle is aﬀected by corruption in
the same way as a private one in that it can oﬀer only fewer services
or lower-quality services for the amount of payroll tax or general tax
received. This means that the beneﬁt package is not as comprehensive
as it could be. However, the list of beneﬁts cannot easily be purged
of those items whose suppliers had bought their slots. This serves to
attenuate the negative relationship between beneﬁts and fraud, at least
as long as incurring a deﬁcit is an option.
Conclusion 3. The comprehensiveness of the beneﬁt package con-
stitutes a ﬁrst dimension of the supply of health insurance. It depends
on at least eight factors, with moral hazard exerting an important lim-
iting inﬂuence.
3.2 Risk Selection Eﬀort
Most policy makers and even many economists believe that “skimming
the cream,” i.e., making an eﬀort to attract the favorable risks, is typical
of private health insurers. However, upon closer examination, this belief
is not justiﬁed. If health insurers were entirely free to grade their premi-
ums according to risk, they would not want to invest in risk selection at
all, and for the following reason (see also Appendix A). An unfavorable
risk of course would be charged a high premium, whereas a favorable
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Table 3.2 Factors aﬀecting risk selection eﬀort.
Factor serves to increase (+)/decrease (−) risk selection eﬀort
Factor
Private health
insurance
Community-based
health insurance
Public health
insurance
Risk aversion of insurer + (n.a.) + ↑ n.a.
Moral hazard + (n.a.) + ↓ n.a.
Size of the beneﬁt
package
+ (n.a.) + ↑ n.a.
Diversity of risks + (n.a.) + ↓ n.a.
Access to risk
information
+ (n.a.) + ↓ n.a.
Sellers’ concentration − (n.a.) − ↑ n.a.
Regulation + (n.a.) + n.a.
Note: ↑ Reinforcement of relationship, ↓ Attenuation of relationship, n.a.: not applicable.
risk would demand and obtain a low premium. Given expected future
health care cost, insurers would adjust premiums such that the expected
contribution margin is equalized across risk groups. Under the pressure
of competition, they simply cannot cross-subsidize one risk group to
the detriment of another because the discriminated group can generate
a more favorable oﬀer from a competing insurer. For this reason, “n.a.”
is entered in Table 3.2 above where appropriate in order to reﬂect the
fully competitive unregulated benchmark, indicating that the factor
considered is not eﬀective. However, in the following it is assumed that
premiums are regulated at least to some extent, imposing more unifor-
mity than warranted in view of actuarial considerations and inducing
an interest in risk selection on the part of competitive health insurers. A
theoretical model analyzing both risk-selection and product-innovation
eﬀort can be found in Appendix A.
3.2.1 Risk aversion of insurer
If premiums have to diﬀer from the expected value of the loss covered
plus loading (see Eq. (3.1) of Section 3.3), the underwriting result of the
insurer has excessive variance. The predicted response of management
to this increased risk exposure depends on the same considerations
as expounded in Section 3.1.1. If management has leeway to pursue
its own interests, inducing risk-averse behavior, then it will undertake
risk selection eﬀorts because it can decrease their own risk exposure in
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this way (see Table 3.2). However, this tendency can be neutralized by
implementing a more or less elaborate risk-adjustment scheme (see e.g.
Van de Ven and Ellis, 2000).
Community-based schemes are subject to the interest in risk selec-
tion because their member-owners certainly are much less diversiﬁed
than the typical shareholder of an insurance company, which makes
them particularly concerned about exposure to a risk that may ulti-
mately spell insolvency. For a public insurer who wields a monopoly,
risk selection is not relevant to begin with, motivating the “n.a”. entries
in Table 3.2.
3.2.2 Moral hazard
A competitive health insurer would want to charge a high premium
to consumers who are particularly susceptible to moral hazard (see
Eq. (3.4) of Section 3.3.6). If this is not possible due to premium reg-
ulation, risk selection clearly is a substitute measure because it can be
used to keep the high-moral hazard types out of the insured population.
3.2.3 Size of beneﬁt package
With a very limited beneﬁt package, diﬀerences in expected contribu-
tion margins between high and low risks typically are not all that large.
This means that the incentive to engage in risk selection is not very
marked either (see the model in Appendix A). Conversely, the more
comprehensive the beneﬁt package, the more health insurers are pre-
dicted to invest in risk election eﬀort. This tendency is likely especially
strong among community-based schemes because once they begin to
oﬀer more beneﬁts, their risk exposure increases, and this increase can
be counterbalanced by a more careful selection of risks.
3.2.4 Diversity of risks
Above all, diversity of risks means that the insured diﬀer widely in
terms of their expected value of loss, i.e., their illness probability
and/or the amount of medical care utilized in the event of illness. The
larger such discrepancies, the more does premium regulation (in the
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limit: uniformity of premiums) induce excess variance in the under-
writing result. A private health insurer is predicted to counter this by
stepping up its risk selection eﬀort. However, the same behavior is pre-
dicted for a community-based scheme (or in fact any nonproﬁt insurer)
as long as running into deﬁcit triggers a sanction of some sort. In their
case this tendency is weaker because traditionally their insured popu-
lation has been very homogenous to begin with (see Table 3.2).
3.2.5 Access to risk information
Risk selection is an attempt on the part of the health insurer to at
least partially overcome an asymmetry of information resulting from
the likely fact that the person to be enrolled knows more about his or
her future health risks than does the insurer. However, genetic infor-
mation may change that. In fact, the availability of such information
permits the insurer to predict future healthcare expenditure of an indi-
vidual with much greater precision. Moreover, refusal to provide genetic
information serves as a signal suggesting that the person disposes of
genetic information indicating he or she constitutes a high risk. This
means that the eﬀectiveness of risk selection eﬀort is greatly enhanced
by improved access to risk information of this type. Accordingly, risk
selection becomes a more attractive alternative for health insurers.
3.2.6 Sellers’ concentration
The importance of sellers’ concentration can be seen from the following
thought experiment (Wilson, 1977). If there were only two companies
(A and B) in the market, risk selection would not make much sense
provided the planning horizon of the two competitors extend beyond
the current period. True, in period 1 insurer A may be able to ﬁlter
out the unfavorable risks. However, it in fact would dump these risks
on B, who in turn would have to resort to risk selection to stave them
oﬀ in period 2. Thus, in period 3 these unfavorable risks would be
seeking coverage with insurer A again. In the end, both A and B would
lose from investing in risk selection. This consideration makes risk selec-
tion in concentrated health insurance markets less likely. This probably
applies to community-based health insurance to a lesser degree because
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their members also own the scheme, fully exposing them to the risk of
insolvency that may be the consequence of a failure to carefully gauge
potential clients. Of course, these considerations do not apply to a pub-
lic insurer, who wields a monopoly.
3.2.7 Regulation
As stated in the introductory paragraph of Section 3.2, a health insurer
who has the freedom to grade its premiums according to risk will tend
to equalize expected contribution margins across risks. Unfavorable
risks, while expected to cause high healthcare expenditure, also pay
a high premium, whereas favorable risks must be attracted by low pre-
miums that reﬂect their low future cost. Arguably, it is premium regu-
lation, seeking to relieve the high risks from “excessive” premiums, that
induces risk selection by health insurers (Pauly, 1984). A means-tested
subsidy paid out to potential purchasers of health insurance with low
incomes could provide an alternative. In this way, this counterproduc-
tive side eﬀect of premium regulation (which is to be expected regard-
less of for-proﬁt status) can be avoided (see Zweifel and Breyer (2005)
for details).
Conclusion 4. The amount of risk selection eﬀort is a second
dimension of supply of health insurance. Induced by premium regu-
lation, it is of great concern to policy makers. Its extent depends on at
least seven factors, the only mitigating one being a high sellers’ con-
centration among insurers.
3.3 Loading: The True Price of Insurance
Since premiums are in part paid back to consumers in the guise of
beneﬁts, they do not reﬂect the price of insurance. Rather, the true
price of insurance is that part of the premium that is not used to pay
beneﬁts, the so-called loading for administrative expense and proﬁt. In
more formal terms, insurers pay an indemnity I to cover a loss against a
premium. The gross premium can be divided in a net premium (π · I),
with probability of loss π depending negatively on preventive eﬀort
on the one hand and a loading on the other. The net premium covers
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the expected amount of beneﬁt to be paid. The loading can be further
subdivided in a component that is a per-unit amount µ associated with
claims processing. The higher the likelihood of a claim being presented,
the more often an administrative process is triggered. The other compo-
nent is a multiple λ of expected beneﬁts net of copayment (symbolized
by a rate of coinsurance c for simplicity), reﬂecting acquisition cost, a
risk premium, and proﬁt. Therefore, a viable insurance contract must
be priced to contain the following elements (Zweifel and Breyer (1997),
ch. 6.2)
P (I) = net premium + loading
= π (V ) · (1 − c) · I + µ · π (V ) + λ · π (V ) · (1 − c) · I, (3.1)
where
P : Premium,
µ: Loading factor for variable administrative expense,
π: Loss probability, probability of illness; 0 < π < 1,π′(V ) < 0,
V : Preventive eﬀort (unobservable),
c: Rate of coinsurance; c < 1,
λ: Loading factor for acquisition cost, risk premium, and proﬁt,
I: Beneﬁt paid in the event of illness.
This equation needs to be completed by the following consideration.
The more complete coverage, denoted by I, the weaker in general are
insured’s incentives for prevention V .1 Taking into account this ex-ante
moral hazard eﬀect, the amount of loading can be written as
Amount of loading = µ · π(V (I)) + λ · (1 − c) · π(V (I)) · I (3.2)
The question arises immediately whether the concept of loading
has any relevance to a public health insurer. It does, and for two
rather diﬀerent reasons. First, a public scheme also has its adminis-
trative expense, which rises as the frequency of claims π increases.
This frequency depends on preventive eﬀort V precisely as with any
private insurer, and V in turn is again negatively related to coverage
1Under certain circumstances the incentives for prevention are higher when coverage
increases. V responds positively to an increase in I when the insured earns a high wage, is
risk averse and/or enjoys a generous sick leave. This can be the case in developed countries
(Zweifel and Manning (2000, p. 417))
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Table 3.3 Factors aﬀecting the net price of health insurance (loading).
Factor serves to increase (+)/decrease (−) risk selection eﬀort
Factor
Private
insurance
Community-
based health
insurance
Public health
insurance
Administrative expenses
(including capital
charge)
+ + ↓ +
Reinsurance +/− +/− ↑ n.a.
Pool size +/− +/ − −
Beneﬁt package + + +
Copayments and caps − − − ↓
Moral hazard + + ↓ + ↑
Quality and proximity of
health care services
+ + +
Regulatory framework +/− +/− ↓ +/− ↑
Fraud and abuse + + ↓ + ↑
Note: ↑ Reinforcement of relationship, ↓ Attenuation of relationship, n.a. not applicable.
I (the ex-ante moral hazard eﬀect). The term µ · π(V (I)) of Eq. (3.2)
therefore applies to public insurance as well. Second, although a public
insurer need not charge for acquisition cost, risk bearing, and proﬁt,
it gives rise to a “loading” that is very similar to the second term of
Eq. (3.2). The larger the expected value of beneﬁts to be paid net of
coinsurance ((1 − c) · π · I), the higher must be the rate of tax levied on
labor income or on sales. Now as is well known, taxes cause ineﬃciencies
because they reduce the volume of transactions; some contracts that
would have been mutually beneﬁcial are not struck under the inﬂuence
of tax. These ineﬃciencies easily amount to 20 percent of transaction
value (see e.g. McMaster, 2001) and thus are of a comparable magni-
tude as λ in Eq. (3.2).
In all, the expression for the loading given by Eq. (3.2) can be
applied to public health insurance as well, at least to a ﬁrst approxi-
mation. The “loading” may of course diﬀer depending on the type of
taxation used to fund the scheme. The amount of loading is inﬂuenced
by several factors listed in Table 3.3.
3.3.1 Administrative expense
Administrative expense must be recovered before the insurer reaches
the break even. They are added to the expected loss. The loading
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factor µ reﬂects these expenses and thus importantly determines the
amount of loading (see Eq. (3.2)). It depends on possible economies
of scale, implying that a critical number of contracts and transactions
may be necessary to reach minimum average cost. The loading factors
also include capital utilization costs, and surcharges for uncertainty
about future cost inﬂation in the healthcare sector and about the loss
probability π.
Community-based schemes are known for their low administrative
expenses because they do not employ much staﬀ. Moreover, the staﬀ
they do have is voluntary in the main. This serves to keep the load-
ing factors at a low value. In fact, members bear part of the costs of
organization by spending time and eﬀort to decide on the product to
be oﬀered and premium to be charged.
Public health insurance constitutes a monopoly, which means that
marketing and advertising expenses are reduced. On the other hand,
a monopoly reduces the pressure to minimize cost. On the whole, the
relationship may be comparable to that in private competitive health
insurance.
3.3.2 Reinsurance
Generally, reinsurance is an expense that reduces the expected value
of proﬁt (if the premium exceeds the actuarial value of losses ceded;
see Doherty and Tinic (1981)). It is therefore similar to administrative
expense, causing the loading to increase, ceteris paribus. The beneﬁt of
reinsurance is that it improves the solvency of the insurer, permitting a
lower value of the loading factor λ. Still, if additional capital is available
at lower cost than reinsurance, it is preferable for an insurer to rely on
the capital market rather than taking out reinsurance.
Reinsurance can be beneﬁcial to community-based health insurers,
whose pool size usually is insuﬃcient for the law of large numbers to
come to full eﬀect. According to the law of large numbers, insurers are
able to estimate π and hence the expected value of beneﬁts to be paid
more precisely when the number of risks increases. Ceteris paribus,
this facilitates the attainment of a given level of solvency. In addi-
tion, the typically nondiversiﬁed individual (member) owners of such
schemes will gain from the lower variance of the surplus (assets minus
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liabilities) generally aﬀorded by reinsurance. This beneﬁt in terms of
variance reduction, however, has to be weighed against the reinsurance
premium. Therefore, low-cost reinsurance may become a precondition
for the viability of community-based health insurance, which most often
do not have access to capital markets.
Reinsurance will hardly be an issue for a public health insurer. Its
large risk pool allows to minimize per-capita reserves (see Section 3.3.3),
to which reinsurance contributes. In addition, these reserves are usually
provided by the government as a lender of last resort; ultimately, the
taxpayers act as the reinsurers of the public health insurer. Compared
to a private insurer, these savings on reinsurance entail a cost advantage
of the public monopolist (see Table 3.3).
3.3.3 Pool size
A large number of insured of similar type allows to estimate the
unknown parameters π and I with greater precision, due to the law of
large numbers. Therefore, the insurer does not have to carry as much
reserves per unit risk for attaining a given level of solvency (Dror and
Preker, 2002, p. 135). The pertinent loading factor λ becomes smaller,
resulting in a smaller total loading.
On the other hand, a large pool size shields the individual insurance
buyer from social control through other members. This control likely
refers to the beneﬁts claimed (I) rather than preventive behavior and
hence π. Increased pool size thus strengthens ex-post moral hazard but
leaves ex-ante moral hazard unaﬀected. The second term of Eq. (3.2)
increases, indicating that the amount of loading increases.
In the case of a community-based health insurer, the trade-oﬀ
between the two inﬂuences can be studied. For instance, the Dana Sehat
schemes in Indonesia are organized in several thousand independent
groups, with approximately 50 to 100 families in each group. Families
are homogenous with regard to household size and income, and due to
the community environment, behavior is closely monitored. Although
the total number of Dana Sehat participants is very large (7 million
people in Indonesia), moral hazard can be controlled eﬀectively, result-
ing in a small loading in spite of small pool size. Taiwan’s “Farmer’s
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health insurance” provides a counter example. There, a risk pool typi-
cally comprises a few thousand individuals (Bureau of National Health
Insurance, 2003). This could lead to a lower value of λ; however, greater
pool size also calls for more complex management, and social control
is undermined. Although information about the total loading is not
available, it is likely to be higher than in Indonesia.
Public health insurance schemes have too large risk pool sizes for
moral hazard eﬀects to be mitigated by social control anymore. There-
fore, expanding the pool even more causes the loading contained in
the contribution to unambiguously decrease due to the law of large
numbers.
3.3.4 Beneﬁt package
An extension of the beneﬁt package increases the likelihood of some
claim being submitted. Therefore, the probability of loss π increases
even without any behavioral modiﬁcation on the part of the insured
(moral hazard eﬀects are dealt within Section 3.3.6). Likewise, payment
may occur under additional titles, resulting in an increased value of
payments I. Therefore, the amount of loading must increase according
to Eq. (3.2).
This argument holds also for community-based and public health
insurance (see Table 3.3).
3.3.5 Copayments and caps
Copayments and caps have three eﬀects on total loading. First, they
serve to limit ex-post moral hazard. Copayments increase the net price
of medical care to consumers, causing them to lower the quantity
demanded, while caps increase the net price to its full market value
when the threshold quantity is exceeded. Therefore, the value of pay-
ments I decreases on average and with it the amount of loading. Caps
have the additional feature of excluding very high values of I, thus
reducing also the (semi) variance of I and hence the loading factor λ.
Second, copayments relieve the insurer of part of the payment in
the advent of illness. As shown in Eq. (3.5) in Section 3.3.6, an increase
in the rate of coinsurance c serves to lower the total amount of loading.
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Copayments and caps thus unambiguously serve to reduce the amount
of loading.
The same arguments hold for community-based schemes. They have
even greater force for public health insurance, where the initial rate of
copayment is zero, resulting in maximum ex-post moral hazard eﬀects.
Indeed, according to Eq. (3.5), the amount of loading reacts most
strongly to a variation in the rate of coinsurance c when (1 − c) = 1,
i.e., when c = 0 initially.
3.3.6 Moral hazard
Moral hazard increases the consumption of health care services by the
insured and thus causes additional costs to the insurer compared to the
situation without insurance. It is a common phenomenon in the insur-
ance and healthcare industry. It is convenient to distinguish between
ex-ante and ex-post moral hazard. Ex-ante moral hazard refers to the
probability of illness π. This probability depends on related preventive
eﬀort on the part of the insured, denoted by V .
While preventive eﬀort can hardly be observed in the context of
health behavior, it generally decreases when the amount of coverage
oﬀered is extended. Ex-ante moral hazard thus results in a positive
relationship between π and the amount of insurance coverage I.
Indeed, because of ex-ante moral hazard an increase in I not only is
associated with a higher gross premium, but a higher amount of total
loading as well. For convenience, Eq. (3.2) is repeated here:
Amount of loading = Λ = µ · π (V (I)) + λ · (1 − c) · π (V (I)) · I.
(3.3)
The derivative of this expression with respect to I (neglecting possible
eﬀects of I on the loading factors µ and λ) is given by
Λ′(I) = µ · π′ (V ) · V ′ (I) + (1 − c) · λ · π′ (V ) · V ′ (I) · I
(−) (−) (−) (−)
+λ · (1 − c) · π (V (I)) > 0. (3.4)
(+)
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With π′ and V ′ negative, the ﬁrst term is positive. For the same reason,
the second term is positive as well, and the third term is positive by
deﬁnition. In analogy to the development in Zweifel and Breyer (1997,
p. 183), the loading usually increases progressively in I, if π′′(V ) > 0
(prevention becoming less eﬀective at the margin) in addition to
V ′(I) < 0.
According to Eq. (3.4), some health insurance beneﬁts may be more
aﬀected by ex-ante moral hazard than others because preventive eﬀort
V responds more strongly to an increase in I. Conversely, this eﬀect
may be mitigated to some extent if health insurance is provided through
the employer, who can at least monitor prevention at the workplace.
This diﬀerence would be reﬂected in a more moderate increase of the
loading (as well as the gross premium) when coverage becomes more
complete or more comprehensive.
Summing up, ex-ante moral hazard likely causes an increase in the
total loading, which may be even progressive in beneﬁts I. There do
not seem to be strong reasons to modify this argument for community-
based schemes. With regard to public health insurance, the govern-
ment’s objective of maximizing the provision of public and merits goods
(see Section 3.1.4) frequently militates against imposing a copayment.
However, this implies that any increase in beneﬁts must go along with
a maximum increase in the loading because of ex-ante moral hazard.
In Eq. (3.4), the amount of loading reacts most strongly to an increase
in beneﬁts if (1 − c) = 1, i.e., when c = 0.
Turning to ex-post moral hazard, this means the tendency of the
insured to demand more medical care (or care of higher quality or
provided by a more expensive provider) after the onset of an illness.
The eﬀect of ex-post moral hazard was illustrated in Figure 3.2 of
Section 3.1.3; there, the role of coinsurance played a crucial role. It
remains to be shown that a decrease in copayment also increases the
amount of loading.
For this, a slightly diﬀerent interpretation of the variable I is
needed. Now I becomes the amount of beneﬁts that is actually claimed
(rather than promised in the contract), which depends on the rate
of coinsurance. Therefore, I has to be replaced by I(c) in Eq. (3.3)
above, resulting in the derivative (note that now preventive eﬀort V is
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predetermined),
λ′(c) = −λ · π · I + λ · (1 − c) · π · I ′(c) < 0. (3.5)
(−) (−)
Therefore, the higher the rate of coinsurance, the lower the loading,
and conversely, the lower the rate of coinsurance, the higher must be
the loading. The ex-post moral hazard eﬀect is given by I ′(c) < 0: the
more the actual utilization of covered services increases with a decrease
in cost sharing, the more marked is the ex-post moral hazard eﬀect.
Ex-post moral hazard problems in community-based schemes are of
minor concern for the same reasons as outlined in Section 3.1. They
beneﬁt from a smaller degree of asymmetry of information, combined
with eﬀective sanctioning mechanisms that serve to contain overuse
(see Table 3.3).
The “loading” contained in the contributions to public health insur-
ance is aﬀected strongly by ex-post moral hazard, again because the
rate of coinsurance is usually zero. With (1 − c) = 1 or c = 0, the abso-
lute value of Eq. (3.5) is maximum. Put the other way around, this
means that moving away from a zero rate of coinsurance would have a
very marked beneﬁcial eﬀect on the loading.
3.3.7 Quality and proximity of healthcare services
Healthcare services of high quality have a direct eﬀect on the total load-
ing because the beneﬁts actually claimed typically are more expensive
(see the eﬀect of a high value of I in Eq. (3.3)). High quality of services
may also aggravate ex-post moral hazard eﬀects. This can be illustrated
using Figure 3.2 of Section 3.1.3 again. Maximum true WTP for such
services must be very high, causing the observed demand function to
run steeply. In this case, ample insurance coverage (low c) results in
a marked discrepancy between true and observed WTP. Graphically,
the distance between quantities A and B becomes larger. In terms of
Eq. (3.5) above, a decrease of the rate of coinsurance c would cause
beneﬁts claimed to increase very strongly. With I ′(c) large – equivalent
to a steep demand function – the loading must increase more strongly
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with a decrease in c. Therefore, the loading depends positively on the
quality of medical services in general.
Increasing proximity of services causes the cost of access and hence
total cost of utilizing medical care to fall. Therefore, the amount of
services claimed I increases, and with it the amount of loading also
(see Eq. (3.5)).
Most members of community-based schemes are located far away
from high-quality healthcare service providers. Any increase in the
proximity of a health care provider therefore is likely to have a consider-
able eﬀect on the cost of access, inducing a particularly marked increase
in utilization. However, these schemes beneﬁt from a degree of mutual
monitoring of their members that does not prevail in the context of
a private insurer. Therefore, the amount of loading may not respond
more strongly to an increase in proximity than in industrial countries.
Increased quality and proximity also drive up the loading compo-
nent in contributions to public health insurance; Eq. (3.5) applies once
more (see Table 3.3).
3.3.8 Regulatory framework
The types of regulation of relevance in this context are again premium
and product regulation. If designed to guarantee solvency, premium
regulation typically amounts to an increased safety loading, which is
reﬂected in λ. Conversely, if regulation is consumer-orientated, it may
result in increased transparency for consumers, enhancing demand and
resulting in a larger risk pool. This means that the reserves held per
unit risk can be reduced, causing λ to be smaller. Turning to product
regulation, this implies that certain procedures in loss settlement have
to be followed, presumably at an increased cost to the insurer. This
drives up the value of the other loading factor, µ. Therefore, the over-
all eﬀect of regulation on the loading is ambiguous, although in the
case of U.S. automobile regulation, Frech III and Samprone Jr. (1980)
found that regulation had a demand-decreasing net eﬀect, pointing to
a positive relationship between regulation and loading.
In community-based schemes, insurance packages and the premium
rate are strictly regulated by the members themselves. This regulation
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does not aim at creating reserves through a loading surcharge on the
risk premium; rather, the insured must come up with additional con-
tributions (often in kind) in the event that the scheme runs a deﬁcit.
The downside of the reduced loading is an increase in the residual
asset variance for members; however, risky insurance is associated with
reduced WTP.
Public health insurance is usually governed by an elaborate regula-
tory framework (in Section 5.2, the view will be expounded that public
insurance is at the high end of a scale, depicting increasing regulatory
intensity). This adds to administrative expense and hence the “load-
ing”; the total amount of loading may still be low due to savings on
the cost of acquisition.
3.3.9 Fraud and abuse
Fraud and abuse are closely related to the institutional framework.
In Section 3.1.8, emphasis was on the corruption possibly occurring
between suppliers of medical inputs and physicians and hospitals. At
this juncture, fraud and abuse by the insured are taken up and their
impact on the loading discussed.
Fraud and abuse are an extreme form of moral hazard. In the case
of ex-ante moral hazard, preventive eﬀort V could be said to turn nega-
tive, implying that insured’s behavior increases the probability of illness
to 1. A negative value of V may well be induced by insurance; in terms
of Eq. (3.4) of Section 3.3.6, V ′(I) is strongly negative as well. This
means that the amount of loading must increase very rapidly with any
increase in I.
Fraud can also occur ex-post, e.g., in the guise of conjuring with
providers to overstate medical bills. Again, this is an extreme form of
ex-post moral hazard that is encouraged by a vanishing rate of coin-
surance (or more generally, the absence of cost sharing). For as soon
as the insured have to pay parts of the medical bill out of pocket, they
have an incentive to resist fraudulent overbilling. In general terms, the
relationship between the degree of cost sharing c and beneﬁts claimed
I is strong in the presence of fraud. For the insurer, the term I ′(c) in
Eq. (3.5) takes on a very large value (in absolute terms), indicating that
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the total amount of loading must increase strongly with a decrease in
cost sharing when fraud is prevalent.
As argued in Section 3.1.3, moral hazard in community-based
schemes, and as such also any extreme form of it, is mitigated due
to the characteristics that prevail in rural communities (close to full
information). Therefore the amount of loading due to fraud and abuse
should not increase much in this variant of health insurance.
A public health insurer is under reduced pressure to control fraud
and abuse; contrary to private insurers, it does not have to compete
for customers through a favorable beneﬁt-cost ratio (to which a low
amount of loading contributes).
Conclusion 5. The third dimension of supply of health insurance
is the loading contained in the premium, which constitutes the net price
of health insurance. It depends on at least nine factors, with copayments
and caps an important mitigating one.
3.4 Vertical Restraints/Vertical Integration
Two forms of vertical restraints (in the extreme: full vertical integra-
tion) can be distinguished, insurer-driven and provider-driven. A third
form of integration is not vertical but lateral. It occurs when a ﬁrm with
main activities outside the sector takes up business in health insurance
or the provision of health care. It will be dealt with only in passing.
3.4.1 Insurer-driven vertical integration
A private insurer can limit its activities to the refunding of medical
expenditures incurred. This amounts to a total absence of vertical
restraints, let alone vertical integration. Such a policy is costly to the
insurer, however, if the providers of medical care have some monopolis-
tic power. In that event, insurance coverage drives up providers’ markup
over marginal cost. This can be illustrated by Figure 3.3, which builds
on Figure 3.2 of Section 3.1.3.
The added feature of Figure 3.3 is two marginal revenue func-
tions (MR). Without insurance coverage, the health care provider faces
the MR function derived from the true demand function (MRt). The
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Marginal cost
Observed demand with a
coinsurance rate of 50% 
True demand
function 
Quantity of health care 
A B
P*
P**
C
C ′′
C ′
MR0
Price and 
marginal
cost of 
health 
care
MRt
Fig. 3.3 Eﬀect of insurance coverage on monopolistic pricing.
quantity satisfying the optimality condition, “marginal revenue equals
marginal cost” (of healthcare services) is A. Accordingly, the monopoly
price is P*, which already contains a markup over marginal cost. With
insurance, the MR function becomes MR0, associated with the observed
demand function. The new optimal quantity of services provided is B,
consistent with a higher monopoly price at P**, reﬂecting an increased
markup over marginal cost. In this situation, the moral hazard eﬀect of
insurance not only consists of an increased quantity consumed (B > A),
but also higher prices (P ∗∗ > P ∗). Since this boosts payments I, the
amount of loading and hence the price of insurance increases as well
(see Eq. (3.4) of Section 3.3.6). One rationale of insurer-driven ver-
tical integration is to avoid this extra moral hazard eﬀect, given by
(P ∗∗ − P ∗). For example, the insurer might employ the health care
provider, with the employment contract stipulating fees as low as
marginal cost (of course, wage income paid would have to contain a
ﬁxed component to make up for the associated loss of revenue on the
provider’s part).
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In more general terms, the provision of health insurance and of
healthcare services may be viewed as two parts of a system. The extra
moral hazard eﬀect then amounts to an externality within the system
that the insurer may seek to mitigate by imposing vertical constraints
on service providers. To be successful, it must itself have a degree
of monopoly power (see Section 3.4.1.1). Therefore, the objective of
the insurer becomes to avoid a double monopoly markup, or double
marginalization (Waldman and Jensen, 2001, p. 468f). The solution
can be a two-part remuneration scheme. First, the provider agrees to
charge a price equal to marginal cost, and second the insurer pays a
ﬁxed amount suﬃcient to motivate the provider to sign the contract.
In the extreme case, the insurer can opt for fully integrating service
providers to avoid this and other externalities. The diﬀerent possibili-
ties form a continuum between independent provision and full vertical
integration (see Figure 3.4).
For example, when full integration would be ineﬃcient, the insurer
may limit itself to ownership of hospitals while contracting with ambu-
latory care providers. It also can mix insurer-managed plans with
plans that are governed by contractual relationships devoid of vertical
restraints. The imposition of restraints can ﬁnally be delegated to, e.g.,
More vertical
integration/restraints 
insurance and health care delivery by the same organization 
hospitals owned by insurer, remaining services through contracting 
ambulatory care provided by the insurer, remaining through contracting 
some health plans managed by the insurer, other plans devoid of vertical 
restraints 
selective /exclusive contracting of insurer with service providers 
contracting between insurer and providers at association level 
any provider can deliver any service to the insurer’s customers
Less vertical integration/restraints 
Fig. 3.4 Forms of vertical restraints and integration imposed by the insurer.
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Table 3.4 Factors aﬀecting insurer-driven vertical integration.
Factor serves to increase (+)/hamper (−) vertical
restraints
Factor
Private health
insurance
Community-
based health
insurance
Public health
insurance
Market power of the insurer + + ↑ +
System eﬃciency gains to be
realized
+ + + ↓
Management know-how of insurer + + +
Contestability of healthcare
markets
+ + ↓ + ↓
Potential to increase entry
barriers to competitors
+ + n.a.
Contestability of health
insurance market
− − ↓ n.a.
Lack of capital of insurer − − ↑ − ↑
Opportunistic behavior and
fraud on the part of insurers
− − ↓ − ↓
Cartelization of service providers − − ↓ − ↓
Legislation prohibiting vertical
restraints
− − ↓ −
Note: ↑ Reinforcement of relationship, ↓ Attenuation of relationship.
a medical association, with the likely result that individual provider
behavior is not very eﬀectively restrained.
The factors encouraging and hampering vertical integration by the
insurer are listed in Table 3.4.
3.4.1.1 Market power of the insurer
This amounts to a necessary condition for the imposition of vertical
restraints. If one of many insurers were to impose vertical restraints,
a given service provider would always have the opportunity to strike
a contract with a competitor that does not seek to impose such con-
straints. Moreover, as long as these constraints do not amount to exclu-
sive dealings, failure to sign up with a particular insurer has negligible
consequences for a service provider. Therefore unless the insurer con-
sidered wields a degree of market power, service providers do not need
to accept any vertical restraints.
Market power of community-based health insurers typically is high
because they as a rule wield a monopoly in the rural area they serve. On
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this score, their degree of market power would certainly enable them
ceteris paribus to impose vertical restraints.
A public health insurer, being a monopolist, can impose strong ver-
tical restrictions on providers in terms of prices and products delivered
if not prevented by legislation. There is a risk of abusing market power;
in particular, purchasing prices may be set so low as to drive foreign
suppliers of drugs and privately funded hospitals out of the market.
This risk is higher under a public insurance scheme than under a com-
petitive private insurance system. Grant and Grant (2002), citing an
unpublished text, refer to the example of a sub-Saharan African country
where payments by national health insurance are so low that service
suppliers have to heavily rely on unoﬃcial charges for ﬁnance. The
authors also use data from Transparency International (several years),
which shows that up to 80 percent of recent transactions with health
workers in certain countries involves an unoﬃcial fee or bribe.
3.4.1.2 System eﬃciency gains to be realized
The double marginalization problem noted above is not the only within-
system externality that can be mitigated by vertical restraints. One
that is also discussed in the industrial organization literature (Carlton
and Perloﬀ, 1999, ch. 12) is the risk of the distributor delivering sub-
standard quality, with adverse reputation eﬀect on the producer. In the
present context, this translates into physicians and hospitals skimp-
ing on quality in the treatment of patients enrolled with a particular
insurer. The solution to this problem can be the creation of a quality
assurance scheme by the insurer.
Another problem that is more peculiar to the healthcare sector is
fraud. As emphasized by Ma and McGuire (1997), the insurer has to
rely on a report provided by the physician to be able to establish the
appropriateness of treatment. The typical vertical restraint used here
is a clause to the eﬀect that service providers are to oﬀer additional
information in case of ambiguity.
A third within-system externality, of particular relevance to health
care, is the “medical technology race.” Given that insurance cover-
age is complete and density of supply high, service providers cannot
3.4. Vertical Restraints/Vertical Integration 227
compete much by price and location. An important remaining param-
eter of competition is medical technology. However, for the insurer it
suﬃces to have few specialized providers oﬀering the most advanced
technology for diagnosis and treatment of a given health condition.
This implies that a technology race among the providers who are con-
tractual partners amounts to a source of ineﬃciency. To avoid it, the
insurer may assign providers to certain health conditions, at the same
time guaranteeing them a minimum number of cases per period. Such
a commitment can be supported by a premium reduction oﬀered to
enrollees in return for a restricted choice of provider, as is often the
case with managed care contracts.
Community-based schemes also face a double marginalization prob-
lem. In the rural areas where they operate, an individual physician or
hospital may be a local monopolist. The fact that they contract with
nonproﬁt institutions is of limited relevance as soon as these providers
must recover their cost. Quite likely any patients treated free of charge
or at a reduced fee are those without any insurance coverage at all.
The deﬁcit incurred must be neutralized by higher fees from those
who do have insurance protection, viz. members of community-based
schemes. Provision of substandard quality therefore can be an issue
since these providers are also monopsonists in their local labor mar-
kets. This induces them to pay a comparatively low wage, making them
unlikely to attract the most skilled healthcare workers. With regard to
fraud, community-based health insurers may beneﬁt from the nonproﬁt
status of especially hospitals; however, public hospitals have a tradi-
tion of cheating to ease bureaucratic processes. The technological race
between competing providers can be excluded from consideration since
community-based insurers are localized primarily in rural areas of low-
income countries, where local monopolies prevail.
Another source of eﬃciency gain is mode of payment. In many rural
areas of low-income countries, service providers are still paid in kind.
However, service providers generally prefer to receive cash. This has
led some schemes to use so-called moneylenders as intermediaries who
transform in-kind contributions into cash, to be paid to providers. In
return, hospitals in particular have been willing to accept prospective
payment for treating scheme members, which constitutes a vertical
restraint.
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A public health insurer, being protected by a monopoly, is under
reduced pressure to reap any system eﬃciency gains through verti-
cal restraints. Therefore, this particular motivation is seen as being
of reduced importance compared to competing private insurers (see
Table 3.4).
3.4.1.3 Management know-how of insurer
Of course, ample management know-how helps to successfully negotiate
and monitor vertical restraints. This is especially true of full vertical
integration, which presupposes knowledge on the part of the insurer on
how to eﬃciently run provider facilities.
Management know-how is very scarce in community-based schemes,
making vertical restraints less likely than conventional, often not fully
speciﬁed contracts with service providers. For public health insurance,
it may be roughly comparable to that of private health insurers oper-
ating in the same country.
3.4.1.4 Contestability of healthcare markets
Contestable markets are characterized by an actual or potential inﬂux
of suppliers, with the potential inﬂux becoming eﬀective as soon
as incentives to enter become strong enough. As the experience of
Managed Care Organizations in the United States suggests, newcom-
ers to the market for medical services (e.g. young physicians) are
more likely to participate, i.e., to accept the corresponding vertical
restraints.
Having their centers of activity in rural areas, community-based
schemes cannot count much on the contestability of the healthcare mar-
kets they deal with. If at all, service providers move from the country-
side to the cities. Therefore, chances for these schemes to ﬁnd partners
who accept vertical constraints are rather slim.
To a public health insurer, increased contestability of healthcare
markets certainly facilitates vertical restraints. However, public admin-
istrators still have to seek out those alternate providers that are avail-
able; their incentive to undertake this eﬀort may be undermined by the
monopoly status of the scheme.
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3.4.1.5 Potential to increase entry barriers to competitors
One motivation for vertical restraints and integration can also be
to foreclose the insurance market to potential entrants.2 For, a new
health insurer has to establish contractual relationships with providers
to build a delivery system. By tying up scarce supply of healthcare
services, incumbent insurers thus can indirectly preclude the entry of
new competitors. Given the complexity of healthcare services and its
high human capital content, controlling a part of healthcare supply
can become a more eﬀective barrier than closing the insurance mar-
ket itself. On the other hand, vertical restraints can be disrupted by
an outsider willing to oﬀer a compensation high enough to make the
healthcare supplier leave the vertical arrangement. However, such pay-
ment tends to be above the level a newcomer is willing to pay (“natural
asymmetry,” as Carlton and Perloﬀ (1999, p. 357) put it).
Community-based schemes beneﬁt from a diﬀerent type of barrier
to entry, which obviates the use of vertical integration to protect their
market from outside competition. This follows from a likely analogy
to credit markets. There, most community schemes are set up along
kinship lines, at least in rural areas. In the case of Nigeria, more than
95 percent of borrowing and lending occurs within a given commu-
nity scheme that usually coincides with a tribe. This suggests that
a challenge to an incumbent community-based scheme would have to
surmount a high barrier in the guise of kin relationships.
To a public health insurance scheme, the potential of vertical inte-
gration to reinforce entry barriers confronting competitors has no
relevance because entry by a competitor is prohibited by law (see
Table 3.4).
3.4.1.6 Contestability of health insurance markets
When insurance markets are and remain contestable, incumbent insur-
ers will be strapped for resources in defending their position, being
mainly absorbed with assuring their survival in the insurance mar-
ket itself. In addition, when insurers have to compete because entry
2For a discussion of the issues in the case of health care, see Preker et al. (2000).
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or exit barriers are low, proﬁtability is driven down to the com-
petitive return; funds and management time will be too scarce to
engage in the imposition of vertical restraints or even full vertical
integration.
With regard to community-based health insurance, barriers to entry
emanate mainly from the characteristics of informal markets. Many
health insurers who might consider entry do not accept in-kind payment
of the premium. This payment may not only take the form of cattle but
also the provision of bonded labor and the cession of land rights. Thus,
there are no barriers to entry that hamper the imposition of vertical
restraints by community-based health insurance, ceteris paribus.
In the case of a public health insurer, the contestability of the mar-
ket for health insurance has again no relevance since the law makes
that market not contestable to begin with.
3.4.1.7 Lack of capital of insurer
This is another impediment especially to integration. Often, full vertical
integration (but less so vertical restraints) requires a capital investment
on the part of the ﬁrm acquiring control. If internal ﬁnance is available,
management enjoys some leeway in deciding about such an investment,
monitoring by the owners of the ﬁrm being incomplete. Lacking internal
ﬁnance, the integrating ﬁrm has to convince banks and investors that
vertical integration will improve proﬁtability and that the debt can be
repaid.
Community-based schemes are organized as mutuals and thus do
not sell tradable shares of ownership. This precludes external equity
ﬁnance, except through increasing membership. However, this alter-
native frequently runs into problems because the scheme may lose
its homogeneity and hence an important cost advantage, as argued
in Section 3.3.3. Finance through, e.g., banks is also diﬃcult because
the scheme cannot oﬀer marketable collateral. However, in some cases
lateral integration may help. Citing the experience of communities in
Bangladesh, Desmet et al. (1999) argue that community-based credit
schemes, which many individuals are already involved in, may pro-
vide the entry point to ﬁnance health insurance. But on the whole,
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lack of capital constitutes an important impediment to integration for
community-based health insurers.
Turning to public health insurance, lack of capital hampers vertical
integration as well because the scheme is not permitted to accumulate
funds or issue debt for such purpose. Initiatives of this type would be
interpreted as a sign of for-proﬁt orientation.
3.4.1.8 Opportunistic behavior and fraud on the part
of insurers
Insurers with a reputation of opportunistic and fraudulent behav-
ior have diﬃculty striking contracts calling for vertical restraints.
By engaging in opportunistic behavior, insurers inﬂict damages on
providers, albeit at the expense of their own reputation and credibility.
This reduces their chances of successfully arranging vertical restraints
with providers. Insurers must therefore ﬁrst establish their credit and
payment reputation among providers in order to win them over for
vertical restraints.
Fraud seems to be a minor issue in community-based schemes
because service providers wield a local monopoly in many cases. If
found cheating, the insurer therefore stands to lose the one available
provider in the region. Since this constitutes an eﬀective sanction-
ing mechanism, it should be easier to agree on vertical restraints (see
Table 3.4).
Opportunistic behavior and fraud can also occur with a public
insurer, undermining the willingness of service providers to enter verti-
cal agreements. However, this eﬀect is attenuated by the consideration
on the part of providers that they have no choice but to sign up if they
want to proﬁt from the demand-enhancing eﬀect of insurance coverage
(see Section 3.3.6).
3.4.1.9 Cartelization of service providers
On the provider side, cartelization makes the imposition of vertical
constraints more diﬃcult. First, the cartel is a means for providers to
jointly increase their incomes. An insurer seeking to negotiate a verti-
cal restraint must beat this benchmark. Second, a cartel must impose
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discipline on its members to be successful, notably with respect to
restricting output. Restrictions on output however conﬂict with the
integrating ﬁrm’s desire to avoid double marginalization, which may
result in the imposition of a minimum volume of sales. In the present
context, a medical association would like to see its members keeping to
a low volume of treatments to support higher fees. However, an insurer
may want to contract for a minimum volume of services at a ﬁxed fee
to avoid upward pressure on fees induced by insurance coverage (see
Figure 3.3 of Section 3.4.1). These intentions are in conﬂict.
To community-based schemes, cartelization of healthcare providers
has little relevance. In rural areas of low-income countries, providers are
suﬃciently protected from competition through mere distance. They
can therefore do without the protection aﬀorded by a cartel.
For a public health insurance scheme, cartelization of providers con-
stitutes an obstacle to vertical restraints and integration in much the
same way as for a private insurer. However, since the cartel has no one
else to contract with, it may agree to a uniform set of vertical agree-
ments to secure the viability of the system (and its demand-enhancing
eﬀect) as a whole.
3.4.1.10 Legislation prohibiting vertical restraints
Restraints can be entirely impossible when there is legislation pro-
hibiting vertical restraints and integration in the healthcare sector
altogether. For example, medical practices and/or hospitals must not
be owned by individuals without a medical degree in several industrial
countries. At the very least, medical management must lie in the hands
of physicians.
For a community-based insurer, there seem to be few legal impedi-
ments to vertical integration. In fact, they were able to closely cooperate
with missionary hospitals in several countries such as Uganda, Kenya,
and Indonesia.
A public health insurer must presumably respect legislation con-
cerning vertical integration in the same way as a private insurer does
since the objective of this legislation is to secure the independence of
the comparatively small businesses of healthcare providers.
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Conclusion 6. The amount of vertical integration is the fourth
dimension of the supply of health insurance. Its insurer-driven variant
depends on at least ten factors, with the avoidance of double marginal-
ization eﬀects being an important motive.
3.4.2 Provider-driven vertical integration
The second type of vertical integration is provider-driven. The typical
case would be a hospital chain that seeks to avoid double marginaliza-
tion in its dealings with insurers that wield a degree of market power.
The chain may also view an insurer as a sales channel, where promo-
tional eﬀort is decisive for the market success of its products. If insur-
ers provide an insuﬃcient amount of advice to future patients, client
matching suﬀers, with unfavorable eﬀects on hospitals’ reputation. A
competing insurer could free-ride on these eﬀorts by letting the other
make promotional eﬀort while selling its own policy at a lower pre-
mium. Such free riding would of course undermine insurer’s incentive
to provide advice. The solution to the problem can be the assignment
of exclusive territories to insurers or even exclusive dealings (Carlton
and Perloﬀ, 2000, pp. 403–405).
In general, the factors encouraging provider-driven vertical
restraints and integration (listed in Table 3.5) are the same ones
hampering their insurer-driven counterparts (listed in Table 3.4 in
Section 3.4.1). With regard to public health insurance, however,
provider-driven vertical integration is regarded as not applicable
throughout (resulting in the “n.a.” entries in the last column of
Table 3.5). The reason is that a hospital or a group of physicians will
ﬁnd it impossible to impose rules on a public agency, e.g., with regard
to the amount of contribution to be paid by the insured. For full inte-
gration, they would even have to acquire property in the agency, which
is not imaginable according to known legal codes.
3.4.2.1 Market power of service provider
As in the case of insurer-driven vertical constraints and integration,
market power is a necessary condition for success. This condition
234 The Supply of Health Insurance
Table 3.5 Factors aﬀecting provider-driven vertical integration.
Factor serves to increase (+)/hamper (−)
vertical restraints
Factor Private health
insurance
Community-based
health insurance
Public health
insurance
Market power of service
provider
+ + ↑ n.a.
System eﬃciency gains to be
realized
+ + n.a.
Management know-how of
provider
+ + n.a.
Contestability of insurance
market
+ + ↓ n.a.
Potential to increase entry
barriers to competitors
+ + n.a.
Contestability of healthcare
markets
− − ↓ n.a.
Lack of capital of service
providers
− − n.a.
Market power of insurer − − ↑ n.a.
Cartelization of insurers − − ↓ n.a.
Legislation prohibiting
vertical restraints
− − n.a.
Note: ↑ Reinforcement of relationship, ↓ Attenuation of relationship, n.a.: not applicable.
usually is not satisﬁed by a single physician but may be met by a
physician network, or a hospital with a large catchment area.
In the rural areas where community-based schemes are typically
active, notably hospitals have the market power to impose vertical
restraints on insurers or to integrate insurance altogether. An example
is provided by the Kisiizi hospitals of Uganda.
3.4.2.2 System eﬃciency gains to be realized
The possible eﬃciency gains are the same as those discussed in
Section 3.4.1.2. It is conceivable that an insurer has enough market
power to increase premiums independently of the cost incurred from
paying service providers. This again results in a double marginaliza-
tion, hurting healthcare providers this time.
Skimping on quality by the insurer is also possible in the guise
of delayed reimbursement of patients, but also of having unjustiﬁed
recourse to small print in its insurance policy. However, it is not quite
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clear whether the loss of reputation caused falls on the service provider
rather than the insurer. In the latter case, there is no externality aﬀect-
ing the healthcare provider.
In the same vein, fraud by the insurer (in particular, failure to pay
in the event of insolvency) might constitute a source of within-system
ineﬃciency. The ensuing loss of reputation is more likely to fall on the
insurer than the service provider, however.
Negative external eﬀects because of insurers engaging in a techno-
logical race do not seem to be an issue either.
Up to this point, incentives for healthcare providers to integrate
health insurance into their operations seem to be rather weak. How-
ever, provider-driven insurance schemes may have some cost advantages
compared to a non-integrated competitor since they already have some
relevant risk information about the insured. This is an eﬃciency gain
accruing to healthcare providers.
Healthcare providers and in particular hospitals dealing with
community-based schemes must take into account double marginal-
ization since a given scheme usually is the monopoly supplier of health
insurance in its region. This consideration speaks in favor of vertical
restraints or even full integration. On the other hand, the possibility of
such a scheme to deliver substandard quality of service is rather remote.
After all, the insured own the scheme themselves, and it is they who
would suﬀer from a lower quality of service than contracted for (Musau,
1999). Also, hospitals are confronted with fraudulent behavior on the
part of community-based insurers, as evidenced by the case study of
Chogoria Hospital in Kenya. Here, schemes running group policies let
non-members (who initially were not identiﬁable as such at the point
of service) present themselves for treatment, creating bad debts for
the hospital (Musau, 1999). A technological race is not an issue, most
community-based schemes lacking the resources for building up elabo-
rate administrative capacity.
3.4.2.3 Management know-how of provider
Management know-how is another factor, facilitating the implementa-
tion of vertical restraints and especially vertical integration.
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The lack of management know-how is particularly marked
in community-based schemes, leading to even less vertical
restraints/integration between health providers and insurers.
3.4.2.4 Contestability of insurance market
If the market for health insurance is contestable, a healthcare provider
considering vertical integration has a chance to strike an agreement
with newcomers. This serves to increase the likelihood of successfully
imposing vertical constraints.
As already outlined in Section 3.4.1.4, community-based schemes
do not face much contestability of their markets. A newcomer would
have to incur extremely high investments to match the advantages of
social control enjoyed by them (see Table 3.5).
3.4.2.5 Potential to increase entry barriers to competitors
Vertical restraints and integration can also serve a strategic purpose by
raising the entry barrier, e.g., to a new hospital. The same applies to
physician networks that set up an insurance scheme to the disadvantage
of outside physicians.
Hospitals dealing with community-based insurers, being local
monopolies, could in principle attempt to protect their markets through
integrating the CBI scheme operating in their catchment area. However,
the little evidence available suggests that the main motive for provider-
driven vertical integration is the prospect of eliminating within-system
ineﬃciencies (see Section 3.4.2.2).
3.4.2.6 Contestability of healthcare markets
Providers ﬁnd it diﬃcult to integrate insurers if their market is con-
testable. In analogy to the arguments proﬀered in Section 3.4.1.6,
resources must be spent on defending their position in the market,
leaving little room for investing in vertical restraints and integration.
Most healthcare providers doing business with community-based
health insurers are located in poor rural areas. This means that even
if there should be any monopoly rents, their amount must be very
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limited. Therefore, the incentive for a new competitor to break into
such a market is weak, resulting in a small degree of contestability.
3.4.2.7 Lack of capital of service providers
Especially physician networks may lack capital because their joint lia-
bility status impedes their access to capital markets. In a deregulated,
competitive market, for-proﬁt hospitals and especially hospital groups
may oﬀer an investment with favorable hedging properties. With a mea-
sure of independence from the capital market and hence comparatively
low beta, they can raise capital at a lower cost than other industries.
Lack of formal capital is a great problem in the case of health-
care providers dealing with community-based insurers. Located in rural
areas, neither physicians nor hospitals have easy access to domestic cap-
ital markets. In addition, with intermediation by moneylenders incom-
plete, healthcare providers have diﬃculty raising internal ﬁnance.
3.4.2.8 Market power of insurer
Insurers with market power require ample compensation to let them-
selves be constrained or integrated.
In community-based schemes, market power of insurers is high since
they usually are the only supplier of health insurance coverage. Ceteris
paribus, a healthcare provider considering vertical integration would
meet with some diﬃculties.
3.4.2.9 Cartelization of insurers
The costs of negotiation are particularly high in the case of cartelization
because all members of the cartel must usually be included.
With regard to community-based schemes, cartelization is of little
relevance for two reasons. First, the fact that they often operate along
kinship lines makes it more diﬃcult to reach horizontal agreements.
Second, as stated in Section 3.4.1.1, community-based schemes usually
constitute a monopoly, causing them to have little interest in the pro-
tection from competition aﬀorded by a cartel. In sum, this results in an
attenuation of cartelization as a factor inﬂuencing vertical restraints.
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3.4.2.10 Legislation prohibiting vertical restraints
There may be legislation prohibiting medical providers to own an
insurer. However, no instance is known to this author, relating to either
industrial countries, or community-based schemes in particular.
3.4.3 Actual examples of vertical integration
As Tables 3.4 and 3.5 and their discussion show, there are factors facil-
itating and hampering both insurer- and provider-driven vertical inte-
gration. This leads to the expectation that depending on the mix of
these inﬂuences, imposition of vertical restraints and attainment of full
vertical integration does occur.
Table 3.6 below contains evidence on some of the existing variants
of insurer- and provider-driven vertical integration as well as lateral
integration. It relates to the competitive case, and community-based
schemes, illustrating that the factors discussed above may result in all
three types of integration in both settings.
Conclusion 7. Vertical integration constitutes the ﬁfth dimension
of the supply of health insurance. Its provider-driven variant depends
on the same ten factors ranging from administrative expense to fraud
and abuse. Those facilitating insurer-driven integration usually hamper
provider-driven integration and vice versa.
3.5 Market Structure
Market structure has several dimensions, among the more impor-
tant being the number of buyers and sellers and the amount of
product diﬀerentiation (Carlton and Perloﬀ, 1999, ch. 1). The num-
ber of buyers has not been an issue in health insurance markets,
even in countries where employers are involved in its provision. With
regard to product diﬀerentiation, it can be said that its degree
increases with the number of sellers unless economics of scope are
very marked (see below). Often, the amount of vertical integration
is also seen as a dimension of market structure. However, in view of
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Table 3.6 Forms of integration.
Variant Private Health Insurers
Community-based
Health Insurers
Insurer-
driven
• Insurer running clinics
and ambulatory care
centers
• Insurer-owned
ambulatory care
centers
BUPA (British United
Provident Association)
oﬀers private health
insurance and
cooperates closely with
domestic healthcare
providers
Atiman Health
Insurance Scheme in
Tanzania cooperates
closely with local
healthcare providers
Provider-
driven
• Hospital setting up
insurance schemes
• Ambulatory care
centers/association of
doctors setting up
insurance schemes
Community hospitals
in rural
Pennsylvania/USA
forming a risk
retention group – a
group of similar
entities that pools its
resources and insures
its own members
• In Uganda the Kisiizi
hospital together
with the Engozi
Society provides a
community based
health insurance
scheme
• The Chogoria
Hospital in Kenya
oﬀers an insurance
scheme
Lateral Companies/cooperatives
active in the credit or
insurance sector
extending their product
line
In Singapore, the
product line is
extended towards banc
assurance activity
Chogoria Hospital
Insurance Scheme in
Kenya focuses
increasingly on the
treatment of HIV
its great importance for the organization of the healthcare sector as
a whole, vertical integration is discussed separately (see Section 3.4).
Thus, the number of sellers (and with it, the degree of their con-
centration) will be retained as the principal dimension of market
structure.
One particular aspect of market structure that will be left out
from this exposition is the legal form of the insurance company. Orig-
inally, most health insurers were mutuals, presumably because a rea-
sonable degree of homogeneity of risks could be attained in this way.
Homogeneity of risks ensures that the variance of total claims to be
paid does not increase without bounds when more risks are added
(Malinvaud, 1972, Appendix). A ﬁnite variance in turn implies that
the expected value of the loss can be estimated with increased precision
(a decreased standard error according to the Law of large numbers),
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permitting the insurer to hold less reserves per unit risk while hold-
ing its probability of insolvency constant (Cummins, 1991). However,
mutuals are at a disadvantage when it comes to raising capital for
expanding their risk pool because they do not issue tradable ownership
shares.
For this reason, the preferred legal form of insurers has become the
publicly traded stock company in industrial countries. Yet, the mutual
form is alive and even thriving in the guise of community-based health
insurance in low-income countries. In the wake of development, with
increasing demand for capital to ﬁnance expansion, these schemes may
change their legal form to become stock companies. However, assessing
the conditions governing such a transition is not the aim of this section.
For this reason, it is taken as given that for the foreseeable future
private health insurers (which need not be stock companies either)
and community-based schemes will continue to coexist in low-income
countries.
Focusing on the degree of concentration on the main descriptor of
market structure, some important factors inﬂuencing it are listed in
Table 3.7. The discussion starts with factors that relate to the demand
side and then shifts to the supply side. Table 3.7 has no entries for public
health insurance for the simple reason that the scheme is assumed to
be a monopoly under all circumstances.
3.5.1 Diversity of preferences
With greater diversity of preferences, a larger set of diﬀerentiated insur-
ance products is necessary for matching supply and demand. This
creates potential for niche products written by specialized insurers,
and therefore a greater number of companies, ceteris paribus. However,
the theory of consumer demand also says that diversity of preferences
becomes eﬀective only if incomes are suﬃciently high. With a very
small income, the attainable consumption set in attribute space is too
restricted to permit choices that lie far apart. Therefore, the number
of proﬁtable product varieties (and usually ﬁrms) is low when income
is low.
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In the case of community-based schemes, there is the countervailing
eﬀect of lacking access to the capital market, which limits the size of the
unit and its geographical expansion. The balance of the two inﬂuences
is an open issue.
3.5.2 Economies of scale
In the case of an insurer, the size of its risk pool may be the source of
economies to scale, deﬁned as decreasing unit cost as a function of the
number of individuals insured. Thanks to the Law of large numbers, a
larger pool size enables the insurer to reduce its reserves per unit risk
without increasing its risk of insolvency (Cummins, 1991, Table I). This
means that the premiums of a large insurer contain a smaller amount
of loading (see Section 3.3.3), which results in a lower premium for a
given amount of expected beneﬁts paid. A large insurer could therefore
gain even more market share, with the so-called natural monopoly as
a possible outcome.
However, a growing pool within a given country may require the
acceptance of less favorable risks, with the consequence of a rise in the
expected value of the beneﬁt to be paid. Also, a larger pool can be
associated with a loss of social control among the insured, encouraging
moral hazard. According to Eq. (3.2) of Section 3.3, both eﬀects cause
the amount of loading to increase, thus counteracting economies of
scale. There does not seem to be very much empirical evidence on this
issue in the domain of insurance, let alone health insurance. In fact, the
available evidence points to constant rather than increasing returns to
scale (see e.g. Fecher et al., 1991). Absent economies to scale, however,
there is no reason to expect a particularly high degree of concentration
on private insurance markets, at least for this reason.
Fujita et al. (1999), argue that economies of scale occur due to
positive spatial externalities. In the present context, this may explain
why health insurers in low-income countries concentrate mainly in
urban areas. Strong centripetal forces that draw businesses closer to
one another (because ﬁrms may want to share a customer base or
local services, have access to trained and experienced labor) outweigh
weaker centrifugal forces that drive businesses farther apart (because
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ﬁrms compete for labor and land). The ﬁrst set of inﬂuences constitute
spillover eﬀects resulting in economies to scale in the guise of lower
costs of administration and advertising. As such, they encourage con-
centration.
Fujita et al. (1999), although not focusing on community-based
schemes, also provide an intuition as to why these are concentrated
in rural areas. There, strong centripetal forces (such as the ability to
serve certain customers and the acceptance of informal market behav-
ior like barter) outweigh the weaker centrifugal forces (such as small
customer base, bad infrastructure, and an underdeveloped capital mar-
ket). Economies of scale thus may occur due to the ﬁrst set of inﬂu-
ences, serving to lower unit costs given the market characteristics of
community-based health insurance.
3.5.3 Economies of scope
Economies of scope prevail in insurance if the cost of providing an
extra unit of coverage in one line of business decreases as a function
of the volume written in some other line. In the context of health
insurance, economies of scope may operate at two levels. First, the
health insurance line may beneﬁt from other business activities of
the same ﬁrm. For instance, it may be possible to market health
insurance through the existing distribution network for selling, e.g.,
banking services. The tendency toward an increased degree of concen-
tration in the health insurance market is indirect and hence not very
marked in this case. Also, the limited amount of available empirical evi-
dence suggests that economies of scope at this level are not important
(see e.g. Suret, 1991).
Second, however, health insurers A and B may realize that while
their products are diﬀerentiated, the expenses for marketing and
administering those of A increase less than proportionately when the
quantity of B’s products is increased as well. The amount of loading
hence would increase less than proportionately with the expected vol-
ume of beneﬁts combined, providing a powerful motive for a merger
of the two companies. With economies of scope (often also called syn-
ergies) of this second type, there is a tendency toward concentration,
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Table 3.7 Factors aﬀecting the degree of concentration of health insurance sellers in markets
for private health insurance.
Factor serves to increase (+)/decrease (−) concentration
Factor
Private health
insurance
Community-based
health insurance
Public health
insurance
Diversity of preferences − − n.a.
Economies of scale +/− + n.a.
Economies of scope + + n.a.
Barriers to entry + + ↑ n.a.
Barriers to exit − − ↑ n.a.
Antitrust policy − − ↑ n.a.
Note: ↑ Reinforcement of relationship, ↓ Attenuation of relationship.
which however does not have to be accompanied with a smaller number
of product varieties. More generally, the number of product varieties
sold in the market does not vary in step with the number of ﬁrms in
this case.
This argument holds for community-based health insurance as well
(see Table 3.7).
3.5.4 Barriers to entry
High barriers to entry exist when a newcomer to the market must make
large investments that cannot be recuperated if entry fails (high sunk
costs). Barriers to entry thus cause the degree of concentration to be
higher than it would otherwise be. They are clearly relevant in the
case of health insurance markets, where a newcomer usually needs to
launch an extensive advertising campaign to gain even a small share
of the market. This investment cannot be recuperated if the newcomer
should decide to withdraw later in time.
A small number of sellers make the negotiation and monitoring of
collusive agreements less costly. For this reason, concentration poses
a threat to price and product competition also in insurance markets.
However, collusive agreements can be destabilized by the emergence
of an additional competitor. This destabilization is less likely to occur
when there are high barriers to entry. Therefore, barriers to entry not
only increase the degree of concentration but may also reinforce the
anti-competitive eﬀects that usually accompany a high degree of con-
centration.
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Barriers to entry in community-based health insurance are rein-
forced by the informal nature of the market (e.g., not all insurance
companies are willing to accept payment in kind). Furthermore the
relationship between the insurance scheme and its members usually
develops over a long period of time (which also helps to minimize
moral hazard eﬀects). A newcomer to this market thus would have
to make a substantial non-recuperable investment to acquire this expe-
rience. This constitutes a barrier to entry facilitating concentration in
the community-based segment of the market for health insurance.
3.5.5 Barriers to exit
When challenged by a newcomer, one or several of the incumbents may
consider exiting from the market rather than defending their position.
However, exit is not an attractive alternative if it entails the loss of
investments that cannot be recuperated (i.e., constituting sunk costs).
For instance, a sales force specialized in health insurance is not an
asset anymore once the ﬁrm leaves the market; even with economies of
scope, it has a reduced value, e.g., in selling life insurance. Barriers to
exit thus keep the degree of concentration lower than it would otherwise
be. However, through their stabilizing eﬀect, they still help to preserve
collusive agreements, reinforcing the anticompetitive eﬀect of concen-
tration. Bailouts of ailing companies also modify the opportunity cost
of leaving the market, thus creating a barrier to exit.
Markets in which community-based schemes operate may be char-
acterized by very high barriers to exit. These schemes beneﬁt from
advantages due to their favorable reputation and established social
control mechanisms (limiting in particular ex-post moral hazard, see
Section 3.3.6), which are lost if an exit from the market occurs. Again,
this constitutes a factor that contributes to a lower degree of concen-
tration, ceteris paribus.
3.5.6 Antitrust policy
In many countries, merger projects must be submitted to antitrust
authorities. Mergers that would result in a notable increase in the level
of concentration are subject to scrutiny according to the rules followed
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both by the U.S. Federal Trade Commission and the Commission of
the European Union. Up to this point, few mergers of health insurers
have been blocked. This does not mean that antitrust policy does not
have an impact on concentration. Indeed, the mere risk of having a
merger proposal rejected may well keep concentration at a lower level
than would otherwise obtain.
Mergers of community-based schemes are very rare, but not because
of eﬀective antitrust policies. Arguably antitrust policies do not take
eﬀect at all in these schemes, which consist of small groups, whose
members share common characteristics like close family and long-run
community relationships. Mergers thus come at the cost of increased
heterogeneity, which seems to greatly outweigh their beneﬁts. The lit-
erature on credit markets oﬀers evidence on the importance of market
segmentation along geographic and kinship lines. Udry (1993, p. 95)
discovered that loans between individuals in the same village or kin-
ship group accounted for 97 percent of the value of transactions. Hardly
any loans were provided to outside communities, as information about
repayment possibilities and village sanctions as a mechanism for con-
tract enforcement were lacking. Similar evidence on informal credit
markets is reported in a case study of rural China (Feder et al., 1993).
Conclusion 8. Market structure as indicated by sellers’ concentra-
tion constitutes the sixth dimension of the supply of health insurance.
It depends on at least six factors, with barriers to entry exerting a
positive and barriers to exit a negative inﬂuence.
4
The Design of an Optimal Health Insurance
Contract
The eﬃciency reasons given above for the existence of SHI with com-
pulsory membership can be convincing only if the design of the SHI
contract is in some sense “optimal” from the point of view of the repre-
sentative consumer (see e.g., Zweifel and Breyer, 1997, ch. 6). In view
of the tendency toward full coverage of most SHI schemes, an issue
of particular importance are the circumstances justifying copayments,
i.e., deviations from full coverage of health care expenditure.
(a) Administrative expense: Copayment provisions can be called
for to save administrative expense such as costs of handling claims. For
this reason, and assuming expected utility maximization on the part of
consumers, it is optimal to exclude partially or entirely expenditures on
health care items that occur frequently but in limited amounts such as
minor medications (Mossin, 1968). More speciﬁcally, if administrative
expense is proportional to the expected volume of health expenditure,
a feature of the optimal insurance contract is a ﬁxed deductible (Arrow,
1963).
246
247
(b) Non-insurable loss: Illness typically involves not only monetry
costs but also non-ﬁnancial losses such as pain and suﬀering. Optimal
health insurance equalizes marginal utility of wealth in all states of
nature but this is not equivalent to full coverage if there are comple-
mentarities between non-monetary and monetary losses. In particular,
if marginal utility of wealth is lower in case of illness than in good
health (due to reduced ability to enjoy expensive types of consump-
tion), optimal health insurance does not fully reimburse the monetary
loss (Cook and Graham, 1977).
(c) Ex-ante moral hazard: If the insurer cannot observe preventive
eﬀort on the part of the insured, a high degree of coverage reduces the
incentive for prevention. Hence there is a trade-oﬀ between risk spread-
ing through insurance and maintaining incentives to keep the risk of
illness low. This trade-oﬀ leads to a premium function, which is convex
in the degree of coverage, such that full coverage should be particularly
expensive (Ehrlich and Becker, 1972). In SHI such a premium function
is nowhere observed, although it could be easily administered because
consumers cannot circumvent the convex schedule by purchasing many
insurance contracts with limited coverage and low premiums each.
(d) Ex-post moral hazard: If the insurer could observe the health
status of the insured, the optimal type of health insurance would pro-
vide indemnity payments, i.e., the insurance payment would not depend
on the insured’s health care expenditure. With asymmetric informa-
tion, however, linking reimbursement to expenditure is inevitable. Still,
copayment provisions are needed to fend against overconsumption of
medical care. The more price elastic the demand for the particular type
of medical services, the higher the optimal copayment rate (Spence and
Zeckhauser, 1971, see also Zweifel and Breyer, 1997, ch. 6). Empirical
evidence, e.g., from the RAND Health Insurance Study (Manning et al.,
1987) shows that there is a small albeit signiﬁcant price elasticity of
demand for most medical services (for a survey of the evidence, see
Zweifel and Manning, 2000).
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Conclusion 9. The optimal health insurance contract suggests
several reasons for stopping short of full coverage. While administrative
expense should be recovered by a deductible, the presence of non-
insurable losses may and that of moral hazard deﬁnitely does commend
a measure of proportional cost sharing, reﬂecting the price elasticity of
demand for medical care in the last-mentioned instance.
5
The Limits of Social Health Insurance
There appears to be at least four types of limits to social health
insurance. First, the incentive structure of social insurers discussed in
Section 3 hampers product innovation. Second, the features of the opti-
mal contract as described in Section 4 imply that coverage provided by
social health insurers needs to be limited in view of moral hazard eﬀects.
A third limit of a more institutional character emanates from the fact
that health risks, while important, are only one type among several
that need to be considered. The fourth and ultimate limit of course is
nothing but the willingness of citizens to pay still higher contributions
for higher quality but more expensive health care, about which some
evidence will be presented at the end of this section.
5.1 Limits Created by Regulation
Traditionally, social insurance is associated with contributions that are
not graded to risk and even uniform across the population. This uni-
formity would be undermined if competitive social health insurers were
to launch new products that fetch a higher premium. The only way to
permit innovation is to let competitors with little potential to increase
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their market share run experiments, which if successful are imposed
on the entire market. Of course, this is a far shot from the innova-
tion process in actual markets, where most innovations fail, adoption
occurs with considerable lags, and some competitors never adopt but
already search for a still more promising alternative. In the case of a
monopolistic scheme, innovation is only possible through a majority
decision in parliament (or even a majority decision of the voters in a
direct democracy). These impediments cause the current provision of
health insurance to lag behind developments of preferences and restric-
tions prevalent in the population by years if not decades (Zweifel and
Breyer, 1997, ch. 11.1).
5.2 Limits Imposed by the Behavior of Insurers
The analysis of Section 3 shows that the capability of innovation, i.e.,
of adapting the insurance product to changing demands, is limited in
social health insurance as traditionally understood. When risk adjust-
ment is imposed in order to “marry” uniform premiums in the face of
diﬀerences in expected cost with competition, insurers considering inno-
vation fear the ﬁnancial sanction that goes along with attracting young
clients (a more formal analysis is provided in Appendix A). Finally, in
the case of social health insurance not provided by a multitude of sup-
pliers but a monopolistic scheme, the incentive for innovation is stiﬂed
even more.
5.3 Limits Imposed by Institutional Design
Undoubtedly, health risks loom large in the lives of citizens. However,
there are other risks confronting people over their life cycles. Adopt-
ing the categories of social insurance, one would want to distinguish
the risks of accident, disability, old age, unemployment, increase in
family size, and death of main breadwinner (Zweifel, 2000b). While
the relationships between these risks have not been fully researched
yet, the available evidence points to positive correlations. This implies
that the three assets to be managed over the life cycle, viz. health,
wealth, and wisdom (Williams, 1998) are likely positively correlated,
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an unfavorable situation for risk-averse individuals. Therefore, insur-
ance as a system should at least mitigate those positive correlations,
e.g., by paying higher than expected beneﬁts in one branch if there is a
shortfall below expected beneﬁts in some other. However, preliminary
research at the macroeconomic level suggests that in several impor-
tant countries, trend deviations of payments are positively rather than
negatively correlated across categories. For example, trend deviations
in payments of German social unemployment insurance are positively
correlated not only with those of old age and pensioners insurance
but also of social, health and accident insurance (see Table 5.1).
Not one out of a total of six correlation coeﬃcients is signiﬁcantly
negative.
Also, social health insurance fails to make up for shortfalls in the
beneﬁts of private insurance. While employee beneﬁts for old age, which
Table 5.1 Correlations of trend deviations in the beneﬁts of U.S. and German social insur-
ance.
OAS MCHI MCSM MA WC DI UI
United States, 1974–1992
OAS* 1
Health†
MCHI
0.82* 1
MCSM −0.29 −0.31 1
MA −0.55* −0.40 0.33 1
Workers
compensation
WC
−0.64* −0.65* 0.31 0.84* 1
Disability DI −0.41 −0.21 0.16 0.93* 0.77* 1
Unemployment UI 0.02 0.28 0.29 0.63* 0.24 0.70* 1
SPI SHI SAI UI
Germany (West), 1975–1993
Social pension
insurance SPI
1
Social health
insurance SHI
0.45 1
Social accident
insurance SAI
0.91* 0.67* 1
Unemployment
insurance UI
0.76* 0.65* 0.83* 1
∗Correlation coeﬃcient signiﬁcant at percent level or better.
† MCHI = Medicare Hospital Insurance, MCSM = Medicare Supplementary Medical, MA =
Medicaid.
Source: Zweifel (2000b).
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Table 5.2 Correlations of trend deviations in the beneﬁts of U.S. and German private and
social insurance.
Social health
Social Social Social un-
Private OAS MCHI MCSM MA accident disability employment
United States, 1974–1992
Life 0.74* 0.47* −0.33 −0.64* 0.49* −0.50* −0.37
Health 0.67* 0.62* 0.02 −0.10 −0.19 0.08 0.34
Disability −0.35* −0.13 0.13 0.80* 0.70* 0.90* 0.58*
SPI SHI SAI UI
Germany (West), 1975–1993
Life 0.27 0.26 0.39 0.25
Health 0.79* 0.56* 0.92* 0.63*
Accident −0.41 −0.15 −0.41 −0.26
Liability 0.43 0.16 0.54* 0.08
∗Correlation coeﬃcient signiﬁcant at percent level or better. Source: Zweifel (2000b).
are counted as social insurance, are negatively correlated with PHI (as
they should be for portfolio variance reduction), trend deviations of
all the other branches of social insurance correlate positively with at
least one of the lines of private insurance (see Table 5.2). Conversely,
again not a single out of 20 coeﬃcients of correlation is signiﬁcantly
negative in the case of Germany (3 out of 21 are negative in the case of
the United States). Of course, this argument could be turned around
to read that German private insurers do not meet their task of mak-
ing up for the shortfalls in beneﬁts occurring within social insurance.
However, 3 out of 10 correlation coeﬃcients are signiﬁcantly negative,
pointing to at least some diversiﬁcation eﬀects within private insurance
(not shown). On the whole, then, social health insurance in Germany
(but in Austria, Switzerland, and the United States as well, see Zweifel
and Lehmann, 2001) might be largely responsible for present insur-
ance systems keeping the volatility of individuals’ assets larger than
necessary.
This (admittedly preliminary) evidence suggests that the same
amount of resource could produce more security for people, or con-
versely, that the same amount of security could be aﬀorded for less
money. This of course serves to limit the attractiveness of social health
insurance for consumers.
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5.4 Limited Willingness-to-Pay of Citizens
The call for reform of current social security systems frequently is based
on the argument that they cannot be ﬁnanced any longer. However,
anything that does not exceed GDP can be ﬁnanced in principle. The
argument therefore must be watered down to the statement that the
WTP of consumers is limited, and mandated expenditure on any good
or service in excess of that limit causes an eﬃciency loss. The problem
with this argument has been that until recently, WTP for public goods
in the health domain was not known.
In the case of Switzerland, some evidence has become available. In
a discrete choice experiment involving 1,000 individuals in 1993, WTP
for additional services to be provided (or rather, compensation required
for accepting cutbacks) by social health insurance in exchange for an
increased premium was measured (Telser et al., 2004, Zweifel et al.,
2006).
Reading Table 5.3 horizontally ﬁrst, one notes that the amounts of
compensation asked are consistently highest for consenting to a physi-
cian list based exclusively on cost criteria (column 1). The sample aver-
age is as high as CHF 103 (=C67 at 2003 exchange rates), or some
38 percent of the country’s average monthly premium of CHF 270 at
the time. Still, the fact that it is ﬁnite speaks against the claim (often
advanced by medical associations) that free choice of physician is virtu-
ally priceless. Selecting physicians on quality or quality and cost (i.e.,
eﬃciency) criteria already requires a lot less compensation, viz. 20 and
16 percent of premium, respectively. These premium reductions can be
granted by current Managed Care alternatives available in Swiss social
health insurance. A possible delay of access to new therapies and drugs
by two years would meet with much more resistance; it would have to
be compensated by no less than CHF 65 or 24 percent of premium on
average. Limiting the drug beneﬁt to generics only would have to be
compensated by small amounts only that cannot be distinguished from
zero. If the drug beneﬁt were not to reimburse drugs used for the treat-
ment of minor complaints, the Swiss on average would even be willing
to pay a small amount (which again is not distinguishable from zero
254 The Limits of Social Health Insurance
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and likely reﬂects “warm glow” (Andreoni, 1995)). Finally, another cut-
back would be the concentration of dispersed existing hospital capacity
in larger, centralized units. In spite of the alleged superior eﬃciency of
such units, this regulation would have to be compensated by CHF 37
or about 14 percent of the average monthly premium.
An argument against SHI in this context is preference heterogene-
ity. If preferences diﬀer, the uniformity imposed entails an eﬃciency
loss. A ﬁrst sign of preference heterogeneity is the fact that compen-
sation asked diﬀers importantly between income classes. For example,
individuals belonging to the top income class demand a compensation
of 220 percent the amount demanded by those of the lowest income
class for voluntarily accepting a physician list based on cost considera-
tions only. Of course, wealthy individuals can always opt out by paying
extra; however, poor individuals do suﬀer a loss because the reduction
by CHF 67 or 25 percent in premiums could in fact be achieved by at
least one health insurer if premium regulation permitted it to pass on
its savings from Managed Care to consumers (Lehmann and Zweifel,
2004).
Preference heterogeneity is also reﬂected in amazingly large regional
diﬀerences. In the case of accepting a physician list based on cost and
quality criteria, the French-speaking minority of Switzerland is so dis-
trustful as to ask for a compensation of no less than CHF 136 per
month, more than ﬁve times as much as the German-speaking major-
ity. Their WTP to avoid other restrictions is consistently more then
twice as high as that of German speakers.
Conclusion 10. There are several limits to social health insur-
ance, ranging from the behavior of social insurers on to moral hazard
eﬀects, institutional design preventing correlations between risks to be
accounted for, and to a WTP for additional coverage that falls short
of its additional cost.
6
Summary and Conclusions
This text revolves about two related basic issues, viz., What are the
reasons for the existence and growth of social health insurance? And,
Are there limits to social health insurance? As to the reasons, demand
for social health insurance may well reﬂect the demand for an eﬃciency-
enhancing invention that overcomes certain market failures plaguing
private insurance markets. In addition, equity considerations may also
provide a powerful motive. On balance, however, the (scanty) available
evidence points to a preponderance of public choice reasons. Social
(health) insurance can be seen as an eﬃcient instrument for gaining
votes in the hands of politicians seeking (re)election (Conclusion 2 in
the text).
Turning to the supply of social health insurance, two settings need
to be distinguished. One is provision by competitive health insurers who
are regulated with regard to premiums and most products, the other, by
a monopolistic public scheme. A simple model generates the prediction
that completing regulation by risk adjustment (whereby insurers having
an above-average share of low risks must pay into a fund that subsi-
dizes those having an above-average share of high risks) undermines
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incentives for product innovation. The basic reason is simple. Innova-
tion tends to attract the young, who are deemed to be at low risks in all
existing risk adjustment schemes; it therefore induces a ﬁnancial sanc-
tion. The monopolist insurer also pursues product innovation to the
extent that it lowers insurance payments (which is of interest to politi-
cal supervisors); however, its incentives are weaker than the competitive
insurer’s given reasonable parameter constellations (Appendix A).
The supply of insurance has ﬁve dimensions, (1) comprehensiveness
of the beneﬁt packages, (2) amount of risk selection eﬀorts deployed
by insurers, (3) the amount of loading contained in the premium,
(4) amount of vertical integration, and (5) degree of sellers’ concentra-
tion. Each dimension depends on several factors, among which moral
hazard eﬀects (that however in their turn can be inﬂuenced by the
design of the contract) are among the most prominent (Conclusions 3
to 8).
The importance of contract design motivates a review of the theory
of the optimal health insurance contract, which also serves as a point
of departure for exploring the limits of social health insurance. And
indeed, this theory calls for a deductible to recover the administrative
cost of providing health insurance. In addition, it may suggest partial
coverage only in the case where the (marginal) utility of wealth is com-
paratively low in the state of sickness, causing material goods not to be
very valuable. It speciﬁcally suggests a positive rate of coinsurance to
combat moral hazard eﬀects (Conclusion 9). However, there are addi-
tional limits to social health insurance. An important one derives from
its institutional nature. From the point of view of risk-averse citizens, an
“umbrella policy” covering not only the risk of illness but also those of
accident, disability, early death of the breadwinner, (unplanned) addi-
tions to the family, and insuﬃcient income in old age could be of consid-
erable advantage to the extent that these risks cause their assets health,
wealth, and wisdom (skill capital) to be positively correlated. However,
consumers may well shy away from creating a public monopoly insurer
with the task and authority to cover all these risks jointly. They might
be more inclined to entrust this task to a competitive insurer that can
be exchanged for another if failing to deliver. These considerations put
another limit on social health insurance. Finally, political pressure to
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constrain social health insurance (and social security more generally)
may reﬂect marginal WTP on the part of citizens below marginal cost.
Conversely, compensation asked for accepting restrictions in the domain
of social health insurance (in the guise of reduced contributions) could
be ﬁnanced by health insurers through cost savings achieved. Recent
evidence from Switzerland relates to this second approach. It suggests
that if health insurers were permitted to fully pass on savings accruing,
e.g., in their Managed Care options, they could compensate the aver-
age consumer suﬃciently to make this options attractive. In all, there
are clear signs of social health insurance encountering several limits
(Conclusion 10).
These limits will become more important in the future as the cost
of health care increasingly occurs toward the end of human life, when
they cannot be recouped by increased contributions any more. More-
over, social health insurance, by modifying the incentives of the great
majority of health care providers of a country, induces the very change
in medical technology that causes the cost of health care to increase
so fast (Zweifel, 2003). The challenge will be to devise contracts that
create incentives for the consumers to make do with the second-latest
medical technology when they are death-bound. However, competitive
private rather than regulated social health insurers likely are better
capable of meeting this type of challenge.
A
Formal Model of Health Insurer Behavior in
Terms of Innovation and Risk Selection Eﬀort
Among the ﬁve dimensions of supply distinguished in the body of
Section 3, only two are retained here for simplicity. Moreover, many of
the inﬂuences listed particularly in Tables 3.1 through 3.5 are neglected
for simplicity. The decision situation of an insurer under the pres-
sure of competition will be analyzed ﬁrst, followed by that of a public
monopoly insurer.
A.1 Competitive Health Insurer
A competitive health insurer can devote eﬀort to innovation (i), result-
ing in new beneﬁts covered but also – and even more importantly –
in a better control of ex-post moral hazard (i.e., moral hazard given
that illness has occurred). Developing managed care alternatives or
contracts with bonus options for no claims are examples of such costly
eﬀorts. On the other hand, the insurer can invest in risk selection eﬀort
(s), trying to “skim the cream,” an activity that has no social value
(assuming that the threat of being found to be a high risk does not
induce preventive eﬀort on the part of consumers). Let µ(i,s) denote
the share of risks in the insurer’s population at risk; this share not
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only depends on s but also on i because innovation typically appeals
to younger consumers (which are lower risks at least on average). The
premium (and hence the present value of their ﬂow P¯ ) is regulated to
be uniform and constant (in spite of lowered expected losses thanks
to innovate eﬀort to keep things simple). However, high and low risks
diﬀer in their probability (πh,πl) of claiming beneﬁts during the plan-
ning period of the insurer. As noted above, innovation eﬀort also has
the eﬀect of lowering the present value of losses L, which are assumed
not to depend on the type of insured, again for simplicity. Finally, both
innovation and selection eﬀorts have a price of one.
Although social health insurers may not per se pursue the maxi-
mization of expected discounted proﬁt EΠ, they still want to ensure
their economic survival in the face of competition. To this end, accumu-
lating reserves is of some importance. However, this ultimately implies
behavior no diﬀerent from maximizing expected discounted proﬁt (of
course under regulatory constraint, which also may result in a planning
horizon that diﬀers from a for-proﬁt insurer). Therefore, the objective
function of such a social health insurer may read as (see Zweifel and
Eisen, 2003, ch. 5.5.2 for a similar model),
max
i,s
EΠ = µ(i,s)
{
P¯ − πhL(i)
}
+ {1 − µ(i,s)}
{
P¯ − πlL(i)
}
− i − s
(A.1)
with
∂µ
∂i
< 0,
∂µ
∂s
< 0,
∂L
∂i
< 0.
Neglecting boundary solutions, the ﬁrst-order conditions for an opti-
mum are given by
∂EΠ
∂i
=
∂µ
∂i
{
P¯ − πhL
}
+ µ
(
−πh∂L
∂i
)
− ∂µ
∂i
{
P¯ − πlL
}
+ {1 − µ}
{
−πl ∂L
∂i
}
− 1 = 0, (A.2)
∂EΠ
∂s
=
∂µ
∂s
{
P − πhL
}
− ∂µ
∂s
{
P¯ − πlL
}
− 1 = 0. (A.3)
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Focusing on Eq. (A.2) ﬁrst, and multiplying it by (i/µ), one obtains
∂µ
∂i
i
µ
{
(P¯ − πhL) − (P¯ − πlL)
}
(−) (−)
−
(
∂L
∂i
i
L
){
µ∗πhL + (1 − µ∗)πlL
}
/µ∗ =
i∗
µ∗
. (A.4)
(−) (+)
The ﬁrst term on the LHS is an elasticity [e(µ,i)], indicating how
much a one percent increase in innovative eﬀort serves to decrease (in
percent) the share of high risks in the insured population. It is treated
as a constant in the following, although its value in general will depend
on the levels of both i and s. The term in brackets is also negative.
With a common present value of premiums P¯ , the high risks cause
a negative contribution to expected proﬁt and the low risks a positive
one. Together, these two terms deﬁne a ﬁrst component of the marginal
beneﬁts of innovative eﬀort. The second component again contains an
elasticity, which indicates the eﬀectiveness of innovation in terms of
lowering the amount of future losses L. The term in brackets mul-
tiplied by L is nothing but the overall expected value of discounted
future losses. This makes sense: Eﬀorts at controlling ex-post moral
hazard have a particularly high marginal beneﬁt if the initial amount
of expected losses is high; accordingly, the optimal value of innovation
s* is higher ceteris paribus (see the RHS of Eq. (A.4)). However, the
last factor (1/µ) shows that this beneﬁt is dissipated across the high
risks; the higher their share, the smaller this second component of ben-
eﬁts of innovation. The RHS of Eq. (A.4) is nothing but the marginal
cost of innovation, again distributed over the high risks.
Turning to Eq. (A.3) now and multiplying it through by (s/µ), one
obtains (
∂µ
∂s
s
µ
){(
P¯ − πhL
)
−
(
P¯ − πlL
)}
=
sx
µ∗
. (A.5)
(−) (−)
The ﬁrst term on the LHS is again an elasticity [e(µ,s)], indicating the
eﬀectiveness of selection eﬀort. Not surprisingly, the term in brackets
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shows the negative overall contribution to expected discounted proﬁts.
Therefore, the greater the diﬀerence between the two types of risk in
the face of the uniform premium, the higher the optimal amount of
selection eﬀort s*, ceteris paribus (see the RHS of Eq. (A.5)). However,
its marginal cost can again be distributed over the number of high-risk
insured µ.
For comparative-static analysis, the point of departure are
Eqs. (A.4) and (A.5), slightly rewritten,
e(µ,i)
{
(P − πhL) − (P − πlL
}
−e(L,i)
{
µπhL + (1 − µ)πlL
}/
µ =
i
µ(i,s)
, (A.6)
e(µ,s)
{
P − πhL) − (P − πlL)
}
=
s
µ(i,s)
. (A.7)
The eﬀect of an increase in regulation R (possibly from a state of
no risk-adjustment scheme) is to decrease the diﬀerence in expected
margins of high and low risks,
∂
∂R
[
(P − πhL) − (P − πlL
]
:=
∂A
∂R
< 0. (A.8)
For future reference, one also has
∂
∂i
(
i
µ(i,s)
)
=
µ − i · ∂µ/∂i
µ2
=
1 − e(µ,i)
µ
. (A.9)
Now, let the ﬁrst-order conditions (A.6) and (A.7) be subjected to a
shock dR > 0. Written in matrix form, the comparative statics read,
using (A.6) to (A.9),
[e(µ,i) − 1]/µ 0
0 [e(µ,s) − 1]
/
µ

[di
ds
]
=
[−e(µ,i) · ∂A/∂R
−e(µ,s) · ∂A/∂R
]
dR.
(A.10)
Applying Cramer’s rule, one obtains
di
dR
=
1
H
(−)
∣∣∣∣∣∣∣∣
−e(µ,i
(−)
) · ∂A/∂R
(−)
0
−e(µ,s
(−)
) · ∂A/∂R
(−)
[
e(µ,s)−1
(−)
]/
µ
∣∣∣∣∣∣∣∣
< 0, (A.11)
A.2. Public Monopoly Health Insurer 263
with H < 0 symbolizing the determinant of the Hessian matrix. Apply-
ing Cramer’s rule once more yields
ds
dR
=
1
H
(−)
∣∣∣∣∣∣∣∣∣∣
[
e(µ,i) − 1
(−)
]/
µ e(µ,i
(−)
) · ∂A/∂R
(−)
0 −e(µ,s
(−)
) · ∂A/∂R
(−)
∣∣∣∣∣∣∣∣∣∣
< 0. (A.12)
Thus, both innovative and risk selection eﬀort are predicted to decrease
provided e(µ,i) < 1, which looks like a reasonable assumption.
A.2 Public Monopoly Health Insurer
Since the manager of a public insurance scheme is a public oﬃcial,
the full set of interactions between a politician, a bureaucrat, and a
voter should be speciﬁed in principle (as e.g. in Alesina and Tabellini
(2004); see also Boldrin and Rustichini (2000) and Hammond and
Knott (1996); for a comparative description of regulation of social
health insurers, see Maarse et al. (2003)). Here, a much simpler alterna-
tive will be presented that has the advantage of facilitating comparisons
with Section A.1 above.
From the outset, there are at least two institutional diﬀerences that
need to be noted. First, a public insurance scheme typically is not
allowed to build major reserves. Reserves are also unnecessary because
economic survival of the scheme is assured by the government. This
means that a public oﬃcial pursuing his or her mission prefers to have
a balanced budget. However, if there is a deviation D from a balanced
budget, the likelihood ρ(D) that the envisaged utility can be in fact
attained decreases. The public oﬃcial faces a certain probability of
losing his or her position (the utility associated with the possible alter-
native employment is normalized to zero for simplicity). The oﬃcial’s
objective function can then be written as
EU = ρ(D) · U(D), with ∂U
∂D
D < 0. (A.13)
If there is a deﬁcit (D < 0), then the oﬃcial has an increase in util-
ity if D increases toward zero (∂U/∂D); if the scheme has a surplus
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(D > 0) however, a further increase in D causes a decrease in utility
(for a similar formulation in the case of a public hospital, see Zweifel
and Breyer (1997), ch. 9.3.2). The respective marginal utilities are nor-
malized to ∂U/∂D = ±1 below.
The second diﬀerence concerns the decision variables. The public
scheme being a monopoly enrolling the entire population, it has no
reason to exert any risk selection eﬀort; moreover, the share of high
risks µ, being exogenous, does not respond to innovative eﬀort i. The
only decision variable remaining therefore is i, innovative eﬀort.
In view of these considerations, and focusing on the case of a deﬁcit
(D < 0,∂U/∂D = 1), one can write the public health insurer’s objective
function as
max
i
EU = maxρ(D)D. (A.14)
Noting that D depends on i, the ﬁrst-order condition for an interior
solution reads
∂EU
∂i
=
∂ρ
∂D
· ∂D
∂i
D + ρ · ∂D
∂i
= 0. (A.15)
This yields
∂ρ
∂D
· D
ρ
= −1, or e(ρ,D) = −1. (A.16)
Note that e(ρ,D) is a constant by assumption. Therefore, the choice of
i** by the public health insurer is completely arbitrary. However, since
i impinges on its budget, i** = 0 is the dominant solution. By way
of contrast, i** > 0 generally pertains in the case of the competitive
health insurer.
B
Types and Eﬃciency Eﬀects of Regulation
The main motive to regulate health insurance is to (1) eliminate the
social costs caused by insolvency by preventing insolvency, or (2) miti-
gate the social costs caused by insolvency while accepting the possibility
of insolvency (Zweifel and Eisen, 2003, ch. 8.1). Indeed, individuals los-
ing their health insurance protection may face hardship and poverty
that aﬀect society as a whole. The two issues are taken up below.
(1) Regulations designed to eliminate insolvencies also seek to avoid
instability in insurance markets that may occur due to adverse selection
processes. Typically, they are very comprehensive and detailed because
current operations of insurers must be monitored to attain the objec-
tive. However, this type of regulation generates ineﬃciency because it
prevents insurers from adopting least-cost solutions. Thus, regulation
aimed at avoiding insolvency under all circumstances may not maximize
social welfare. Once private insurance schemes are fully regulated – such
that, e.g., prices, quantity and quality, of private insurance products
are determined outside the market mechanism – resource allocation is
likely to deteriorate. In other words, wrong insurance product pricing,
wrong insurance packages, and reduced competitive behavior may lead
to an ineﬃcient and inequitable allocation. Table B.1 below provides
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Table B.1 Regulations that tend to lower eﬃciency.
1 Imposed premiums Lack of incentive signals
Undermines price competition
Premium fails to reﬂect expected costs
Disturbs balance of underwriting and investing
activities
2 Obligation to provide
speciﬁc products,
approval of product
Restricts product competition
Does not reﬂect individual beneﬁt-cost estimates
3 Rules on active/passive
ownership (vertical
integration)
Prevents insurers from ﬁnding the optimal degree of
vertical integration
4 Obligation to provide
certain beneﬁts and/or to
insure certain risks
Can make insurance not viable
Does not reﬂect individual beneﬁt-cost estimate
5 Separation of lines of
business
Loss of synergy eﬀects both for insured and insurer
(allocation of reserves is not optimal)
6 Budget approval Hampers product innovation
7 Rules on investments May prevent insurers from obtaining maximum
expected return for a given volatility
8 Subsidies and tax
exemptions in favor of
insurers
Justiﬁed if insurers provide a public good (e.g. cohe-
sion of society)
Induces overconsumption of insurance
9 Obligation to contract
with providers
Lowers pressure on providers to reach eﬃciency
an overview of regulations that tend to lower eﬃciency, along with a
short explanation. For example, budget approval (item 6) stiﬂes prod-
uct innovation because, apart from possible delays, the insurer runs the
risk of having the cost of innovation disapproved.
(2) However, regulation can also be designed to reduce social cost once
insolvency occurs by making insurers bear that cost. One way to inter-
nalize it is to require the deposit of reserves, another, the establishment
of a guaranty fund ﬁnanced jointly by the insurers (items B and F of
Table B.2). These measures go a long way toward eliminating hardship
of insured in the advent of insolvency. Even these regulations are not
without their cost, however, because, e.g., the reserves deposited could
usually be invested at a higher rate of return. In addition, there is a
direct cost of administering these regulations. On the whole, however,
regulations motivated by the objective of internalizing the social cost of
insolvency seem to have a better chance of being eﬃciency-enhancing.
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Table B.2 Regulations that tend to enhance eﬃciency.
A Licenses for insurers Serves to lower probability of insolvency
B Minimum capital Serves to lower probability of fraud
C Minimum liquidity
requirements
Serves to lower probability of insolvency
D Reinsurance schemes Serves to lower probability of insolvency
E Provision of a guarantee
fund
Serves to lower probability of insolvency
F Industry-wide insolvency
fund
Serves to lower probability of insolvency
G Provision of information
to regulators and
consumers
Serves to increase transparency
H Agreed-on accounting
procedures, internal and
external auditing
Serves to increase transparency
I Mandatory risk
adjustment scheme
among insurers in the
presence of adverse
selection
Avoids cream-skimming by insurers
Often a complement of premium regulation
Finally, insurance regulation may have the objective of creating
demand for private coverage, which is seen as a precondition for an
expanded provision of private health care and the reaping of eﬃciency
gains associated with it (Griﬃn, 1989, p. 23).
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